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ABSTRACT 
Objective 
Moderately preterm infants account for a large proportion of admissions and bed-days 
in neonatal units. Determinants of length of hospital stay, contemporary measures of 
morbidity by gestational week and risk factors predicting neonatal morbidity have been 
poorly studied. The overall purpose of this thesis was to fill these gaps with knowledge 
to make neonatal care more effective, and to improve short- and long-term outcome for 
moderately preterm infants. 
Methods 
Observational studies on length of hospital stay for moderately preterm infants in a 
longitudinal perspective over 20 years (Paper I) and a cross-sectional multicenter 
survey (Paper II) were performed. Risk factors for prolonged length of stay were 
determined in Paper II. Neonatal outcomes were studied in two national population-
based studies. Paper III explored neonatal morbidity and interventions stratified by 
gestational week. In Paper IV, rates of transient tachypnea of the newborn (TTN) and 
respiratory distress syndrome (RDS) among moderately preterm infants were compared 
to corresponding rates in late preterm to term infants, and risk factors for these acute 
respiratory morbidities were evaluated.   
Results 
Paper I found that length of stay decreased by an average of 14 days from 1983 to 
2002, in spite of no concomitant decrease in neonatal morbidity. Paper II showed that 
only 13% of the variation in length of stay in Swedish neonatal units (which differed up 
to two weeks) could be attributed to neonatal morbidity. In Paper III, overall rates of 
common neonatal morbidities were found to vary between 15 and 59% in moderately 
preterm infants, with a strong inverse relation to birth weight standard deviation score 
and gestational age at birth. Paper IV demonstrated that besides low gestational age, 
Cesarean section, male sex and low Apgar score are associated to significantly 
increased risks for TTN and RDS in moderately preterm infants. 
Conclusions 
Whereas neonatal morbidity has remained essentially unchanged and high, length of 
hospital stay has decreased significantly for moderately preterm infants during the last 
20 years. Our data suggest that organizational factors of neonatal care are responsible 
for this development. Moderately preterm infants continue to face a considerable risk of 
acute respiratory morbidity, which is also predicted by low gestational age, multiparity, 
Cesarean section, low Apgar score and male sex.  
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1 INTRODUCTION 
A rapidly increasing number of infants are surviving preterm birth since the 
introduction of modern neonatal care three to four decades ago. Today in Europe, an 
estimated 9 million children and adolescents have been born preterm. Of all preterm 
infants, more than two thirds are born moderately preterm which approximates 6-7 
million European citizens under the age of 18. In Sweden, 4.4-4.7% of all newborns or 
4,500-5,000 in absolute numbers every year are born moderately preterm. A large 
proportion of these infants are admitted to neonatal care units, some for observation and 
others for active medical treatment. Due to their large numbers, the moderately preterm 
infants consume a considerable part of neonatal resources and bed-days. 
 
Although extremely preterm births are associated with the highest risks for adverse 
outcomes, the much larger group of moderately preterm infants may imply a greater 
attributable health problem, not only in the neonatal period but also in later life. 
Moderately preterm infants have been identified as a low risk group by both parents 
and professionals for decades - contributing to the fact that their peri- and neonatal 
exposures and morbidities are poorly described - however, recent studies show 
increased risks for adverse long-term outcomes such as hypertension, diabetes, 
disability, psychiatric disease and low income.1-4 
 
The primary aim of this thesis was to highlight the group of infants born at 30-34 
gestational weeks and to provide up-dated information regarding their length of 
hospital stay and neonatal morbidity. Length of hospital stay was analysed both in the 
past and in the present, and different factors that may contribute to the length of stay 
were determined. Rates of neonatal morbidity and use of neonatal interventions in 
infants born at 30-34 weeks were described in detail and possible risk factors for 
adverse neonatal outcome were explored.    
 2 
2 BACKGROUND 
2.1 VITAL STATISTICS IN SWEDEN 
2.1.1 Population and birth numbers 
The Swedish population is currently 9.4 million (31 december 2010). The country is 
sparsely populated with 21 inhabitants per square kilometer and a majority of the 
population is located in the southern part of the country. About 85% of the Swedish 
citizens live in urban areas. In 2010, 14.7% of all inhabitants in Sweden were born 
outside the country.5  
 
In the recent years, birth rates in Sweden have been approximately 110,000 per year. In 
2009, perinatal mortality was 5.6/1,000 and neonatal mortality, defined as deaths of live 
births within the first 28 days of life, has varied between 1.4 and 2.5/1,000 live born 
infants in the last decade (Figure 1). Pregnancy care is free of charge and virtually all 
pregnant women adhere to a standardized antenatal care program starting in early 
pregnancy;6 97% of all pregnant women have a routine ultrasound examination at 16 to 
18 postmenstrual weeks to determine gestational age (GA). In 1973, 91% of primiparas 
were younger than 30 years whereas in 2009, the corresponding figure was 59%.7 
Between 2004 and 2008 (i.e., the main study period of this thesis), 22% of the mothers 
had been born outside the Nordic countries (i.e., Sweden, Denmark, Finland, Iceland, 
and Norway), 25% were overweight (body mass index (BMI) >25 kg/m2) in early 
pregnancy, daily smoking in early pregnancy decreased from 8.8 to 6.9%, and 47% had 
higher (college or university) education.8 The Cesarean section rate was 17% and 
approximately 10% of all newborn infants were admitted to the neonatal unit. 
 
2.1.2 Preterm births 
Of all live born infants in Sweden, approximately 5.6% are preterm, i.e., born before 37 
completed gestational weeks and approximately 1.2% are very preterm, i.e. born before 
33 completed gestational weeks. As opposed to many other countries, the rates of 
preterm birth in Sweden have been rather stable since the beginning of the 1970:s.8 In 
the US, 10.5% of pregnancies were shorter than 37 weeks in 1990 and this number 
increased by 21% to 12.7% in 2006.9 
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Figure 1. Neonatal mortality, preterm delivery and multiple births in Sweden 1973-2008. 
Source:www.socialstyrelsen.se8
 
 
2.2 ORGANIZATION OF NEONATAL CARE IN SWEDEN 
2.2.1 The Swedish health care system 
Health care in Sweden is a universal public system where all citizens have equal access 
to health care services. The system is mainly financed by taxes and although the 
government has the overall responsibility for national health affairs, financing and the 
task of providing health care is decentralized to 21 political and geographical county 
councils. In addition to the universal health care system, there are also private medical 
care alternatives. Some of these are connected to the tax-paid public system and others 
are financed by private insurances or paid directly by the patient. Hospitals are 
subdivided into regional (university) hospitals with highly specialized care, county 
hospitals with specialized care, smaller hospitals with basic care and out-patient 
primary care units.  
 
2.2.2 Neonatal care 
Neonatal care is provided by 39 neonatal units located in an equal number of hospitals 
responsible for births in pre-defined geographic areas. Highly specialized intensive care 
and care for extremely preterm or critically ill infants are centralized to seven regional 
hospitals, each of which corresponds to a larger health region of the country (Figure 2). 
These university hospitals have neonatal units of level III according to Stark10 and are 
situated in the following cities: Umeå (Northern Region), Uppsala (Uppsala-Örebro 
region), Örebro (Uppsala-Örebro region), Stockholm (Stockholm region), Göteborg 
(Western region), Linköping (South Eastern region) and Lund (Southern region).  
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2.2.3 Neonatal unit levels 
There is evidence that risks for neonatal mortality and morbidity in extremely preterm 
or low-birth weight infants are higher in infants born at hospitals providing basic or 
specialty care as compared to infants born at hospitals with subspecialty neonatal 
care.11,12 Transfer between units has also been associated with a higher risk of mortality 
in very preterm infants.13 In a Swedish setting, level of neonatal care influenced risk of 
mortality in preterm infants at gestational ages below 28 weeks.14,15   
 
The US Committee on Fetus and Newborn 2003-2004 has proposed that neonatal units 
should be classified in three levels according to the functional capability and resources 
of neonatal care.10 In this classification, Level I (basic) units provide hospital-based 
neonatal care including resuscitation, evaluation and postnatal care of healthy newborn 
infants and stabilization of ill or immature infants until transfer to a higher level of care. 
Level II (specialty) units care for infants born at more than 32 weeks’ gestation with 
physiologic immaturity or who are moderately ill. The units have access to nasal 
continuous positive airway pressure (nCPAP) treatment and mechanical ventilation can 
be provided for a short duration of time. Level III (subspecialty) units provide 
continuous life-support and care for high-risk infants and those with extreme 
immaturity or critical illness. The committee suggests that regionalized perinatal care 
systems are created to ensure that each newborn infant is delivered and cared for in an 
appropriate facility. Furthermore, the committee recommends uniform national 
standards on training of personnel, equipment and organization of services at each level 
of neonatal care. Finally, the importance of proper evaluation at each level of neonatal 
 
Figure 2: A map of health care regions and municipalities of Sweden.  
Picture by: Lokal_profil. CC-BY-SA-2.5. 
 
   Northern Region  
   Uppsala-Örebro Region  
   Stockholm Region  
   South Eastern Region  
   Western Region  
   Southern Region  
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care by collection of population-based data on short- and long-term outcomes is 
stressed. 
 
Swedish neonatal units have been divided into a three-level subclassification similar to 
the American recommendations. According to the classification in the Swedish 
Perinatal Quality Register (PNQ), eight neonatal units provide neonatal care 
corresponding to level I, 23 are level II and eight provide highly specialized care and 
are classified as level III. In addition to these, there are several smaller hospitals 
without an organized in-patient neonatal unit that can perform resuscitation, care for 
and evaluate healthy newborn infants, and stabilize ill or immature infants until they 
can be transferred to the proper level of care.  
 
2.2.4 Recent organizational changes in neonatal care 
In the last decade, neonatal care has improved not only in the field of new medical 
treatments and interventions such as antenatal steroids, surfactant replacement therapy 
and improved mechanical ventilation devices, but also as a result of an increasing 
interest in organization of care and care practice. It has been reported that the 
environment in the neonatal care unit and family involvement may be of importance for 
the outcome of the newborn infant and the length of hospital stay.16-20  
 
Family centered care 
The newborn infant’s need for a quiet and individually adapted environment includes 
proximity to the parents and in particular to the mother.21 In the design of modern 
neonatal units in Sweden today, much thought is usually given on how to care for the 
mother and the ill infant as close to each other as possible. In several modern neonatal 
units, infants that are physiologically stable but still need specialized care, can stay in 
so-called “family-rooms” together with one or both parents. A randomized controlled 
trial of family care (from birth) versus standard care in a level II neonatal unit in 
Stockholm showed a reduction of length of hospital stay by 5 days in the family care 
(intervention) group.16 The results suggested that family care had a stronger impact on 
length of hospital stay in the more preterm infants. There were no differences in 
neonatal morbidity between the two groups except for a small decrease in moderate 
bronchopulmonary dysplasia (BPD) in the intervention group. 
 
NIDCAP 
Neonatal Individualized Developmental Care and Assessment Program (NIDCAP) is 
an early intervention care developed by Als et al. to help create a more agreeable 
environment and care that is customized to the developmental stage of the  individual 
infant.22 This program has been reported to decrease neonatal morbidity,23,24 to have 
positive effects on later neurobehavioural  development24 in very preterm infants and 
has been implemented in many Swedish neonatal units.  
 
Organized Home Care  
In 1998 an early discharge program was tested in two Swedish hospitals as an attempt 
to shorten length of stay (LOS) in uncomplicated cases.25 A randomized control trial 
included physiologically stable preterm infants, allocated either to an early discharge 
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group with organized home care, or to a control group receiving standard care. In the 
early discharge program, parents were educated to gavage feed and resuscitate and 
they had access to domiciliary support from specialized nurses by telephone or home 
visits. Apnea monitors for home use were used until gavage feeding was ended. The 
study showed that length of stay could be shortened by an average of nine days in the 
early discharge group. Quality control of the early discharge program showed no 
increase in readmissions, no increase in infant morbidity and no mortality after 
discharge,25 a continuously large proportion of breastfed infants and a high 
satisfaction rate among parents.26  
 
2.3 PRETERM BIRTH 
2.3.1 Definitions of preterm birth 
Preterm birth has been defined as birth before 37 weeks (or before 259 days) after the 
onset of the mother’s last menstrual period. Term birth is accordingly defined as birth at 
37-41 weeks (or 259-293 days) gestation and post term are births at 42 weeks or more 
(≥294 days) (Figure 3). This definition is recognized by the World Health Organization, 
whereas the subdivision of preterm birth is more arbitrary and varies between different 
settings. The most common terminology uses extremely preterm birth (<28 weeks GA), 
very preterm birth (<32 weeks GA), moderately preterm birth (32-36 weeks GA) and 
late preterm birth (34-36 weeks GA).27 However, the interval between 32 and 36 
gestational weeks has been subject to a variety of different terminologies, including 
“late preterm,” “near term,” “marginally preterm,” “moderately preterm,” “minimally 
preterm,” and “mildly preterm”, terms which all can be found in the literature.28 The 
terminology “completed weeks” may also be confusing. To clarify, a combination of 
gestational weeks and days is commonly used. For example, 34 completed weeks 
includes pregnancies with a gestational age of 34 weeks + 0 days to 34 weeks and 6 
days. 
 
In this thesis entitled “Moderately Preterm Infants”, the study group was defined as 
infants born at 30+0 to 34+6 gestational weeks (Figure 3). We are aware of the 
inconsistency with the most commonly used definition of “moderately preterm” in the 
recent literature,27 but we have chosen to keep our original gestational age limits 
throughout the work to be able to compare outcomes and results between the included 
studies. In addition, preterm infants born at 35-36 weeks of gestation are routinely 
cared for in the maternity unit, whereas preterm infants born at or below 34 weeks of 
gestation are admitted to neonatal units in Sweden, generating data in our neonatal 
unit register (“PNQ”). 
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Figure 3. Common classifications of preterm birth and the definition used in our study group. 
 
  
2.3.2 Determination of pregnancy length 
Ultrasound measurement of the fetal size was introduced in 1973 in Sweden and has 
been the routine method of dating pregnancy length in the country since at least 1996.6 
Although first trimester or early second trimester ultrasound for pregnancy dating is 
considered more accurate than last menstrual date, it can sometimes cause systematic 
underestimation of pregnancy length, for example in early fetal growth restriction and 
in female fetuses.29 Repeated routine fetal ultrasonography assessments have not been 
implemented in Sweden.  
 
Compared to ultrasound dating, determination of pregnancy length according to last 
menstrual date is considered to systematically assign pregnancies as 2-3 days longer 
and to overestimate the number of post term births. This phenomenon may be partially 
caused by delayed ovulation and/or early growth restriction30,31 and must be 
remembered when comparing studies on preterm birth that originate from different 
methods of pregnancy dating.  
 
2.3.3 Etiology and mechanisms of preterm birth 
There are three major obstetric events leading to preterm birth (Figure 4), all of them 
associated to separate causal chains. The distribution of these obstetric precursors for 
preterm birth depends on gestational age. Spontaneous preterm labor with intact 
membranes are either preterm early idiopathic activation of the complex endocrine 
system involved in the onset of labor or a result of a pathological chain of events 
starting with infection/inflammation or trauma.27 Preterm premature rupture of 
membranes (PPROM) is thought to result from an asymptomatic intrauterine infection 
leading to inflammation of the amnion and degradation of the fetal membranes.32 Most 
of the pregnancies with PPROM end with spontaneous onset of labor within a week. A 
well-known complication to PPROM is intrauterine and fetal infection. Deliveries on 
maternal or fetal indications can result in an induced vaginal delivery or a Cesarean 
section. 
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Figure 4. Obstetric precursors of preterm birth. From Goldenberg et al.27   
 
 
Risk factors for preterm birth 
Preterm birth can be seen as a syndrome caused by several interacting mechanisms. Of 
the currently identified risk factors, four major groups can be seen: maternal 
characteristics, pregnancy risk factors, risk factors mediated by inflammation and 
genetic factors. One isolated risk factor is commonly not enough to cause preterm 
birth.33 However, if one or several of the identified risk factors can be prevented, the 
rate of preterm birth in a population could perhaps be reduced, resulting in large 
positive health effects.34 
 
Among maternal characteristics, it is well known that certain ethnic groups have 
increased risks for preterm birth. In African-American women, preterm birth is as 
common as 16-18% whereas the Caucasian population have an incidence of 5-9%. The 
causes for this difference are unknown.35 A low pre-pregnancy BMI is associated with 
an increased risk of preterm birth whereas a high pre-pregnancy BMI is associated with 
increased risks for some congenital anomalies, preeclampsia and diabetes mellitus 
which are factors that also increase the risk of preterm birth. After a first preterm birth, 
the risk of another preterm birth is increased 2.5-fold.27 The risk of repeating very 
preterm birth is higher than the risk of repeating moderately preterm birth.36 After a 
pregnancy complicated by preeclampsia, the next pregnancy is at a doubled risk of 
preterm birth, despite the absence of preeclampsia in that second pregnancy.37   
 
Second, some pregnancy characteristics are known to influence gestational length. An 
inter pregnancy interval of less than six months results in a doubled risk of preterm 
birth, presumably because the uterus takes more time to recover from the first 
pregnancy. Multiple pregnancy is a strong risk factor for preterm birth. Nearly 60% of 
all twins are born preterm, the majority from spontaneous labor or PPROM. The 
suggested cause for these preterm births is overdistension of the uterus.33 Vaginal 
bleeding, polyhydramniosis, oligohydramniosis are all associated to increased risks for 
preterm birth.27  
 
Third, inflammation has been suggested to be an important cause of preterm birth. The 
mechanism is thought to be a chemical degradation of the fetal membranes from 
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inflammatory mediators such as cytokines and prostaglandins which may lead to a 
premature disruption of the membranes, and stimulation of uterus contractility and 
cervix maturation, which may initiate preterm labor.38 Systemic and/or local 
inflammation responses have been reported or suggested in maternal abdominal 
surgery, high levels of psychological stress, smoking,39 use of smokeless tobacco 
(snuff),40 intrauterine infection, bacterial vaginosis and other infections such as 
pyelonephritis, pneumonia, appendicitis and periodontal disease.27,33 Quantitative 
genetic analyses show that around 25% of the variation in preterm birth is explained by 
maternal genetic factors, whereas fetal genetic factors (inherited from both the mother 
and father) only marginally influence the liability in preterm birth.41 Intrauterine 
infections are often chronic, sometimes asymptomatic and are overrepresented in 
preterm births before gestational week 34 but not thereafter.38  
 
Finally, genetic factors seem to contribute or modulate risk of preterm birth. Sisters to 
women who have undergone preterm birth have an 80% increased risk of preterm 
birth.41 Grandparents of women having a preterm birth are more likely to have been 
born preterm themselves. Certain single-nucleotide polymorphisms have been 
associated to preterm labor and PPROM.27  
 
Obstetric management of a threatening preterm delivery must be a balanced decision 
between the risk of a continued pregnancy for both mother and infant and the risk of 
preterm birth for the infant. This decision itself must take into account the cause for 
preterm labour or iatrogenic delivery versus the estimated risk of neonatal 
complications, in relation to gestational age and other risk factors that may alter the 
infant’s outcome. 
 
2.3.4 Evaluating outcomes of preterm birth 
Information from studies on short- and long term morbidity for preterm survivors of 
neonatal intensive care is crucial to four groups of people; those who are born preterm, 
parents that face preterm birth, physicians and other staff members that care for preterm 
infants and researchers that interpret, compare and communicate results of scientific 
works to others.42 To be able to compare results from different study populations, one 
must use defined and uniform criteria for inclusion, exclusion and outcome measures. 
The disparities in registration of perinatal death, especially around the border of 
viability in extremely preterm infants, exemplify this problem.43 Another example is 
the suspected selective bias in prospective studies comparing socioeconomic status on 
risk of preterm birth, where mothers who consented to participate in a study that 
“requires time, effort and psychological investment” may have a lower risk of preterm 
birth.44 There are also the differences in gestational age estimation to take into account 
(section 2.3.2). 
 
2.4 MORBIDITY IN NEWBORN INFANTS 
2.4.1 General morbidity 
The panorama of morbidity in newborn infants is dominated by the transition from 
intrauterine to extra uterine life. Some of the neonatal diagnoses can almost be 
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considered physiologic changes, while others are life threatening pathologic processes. 
The most common group of diseases (except hyperbilirubinemia) is disorders of the 
respiratory system. The spectrum of severity ranges between self-limiting mild 
symptomatic disorders and fulminant respiratory distress demanding intensive care. 
Another common morbidity is infections, due to the immature immune system and 
vulnerability to pathogenic organisms in both term and preterm infants.  
 
2.4.2 Specific morbidity in preterm infants 
Transient tachypnea of the Newborn (TTN) 
TTN or wet lung disease is a common disorder characterized by a delay in absorption 
of fetal lung fluid. TTN affects both preterm and term infants, and presents 
immediately after birth. Chest X-ray films show prominent perihilar vascular marking, 
patches of infiltration and an increased amount of interstitial fluid. The lungs may be 
hyperinflated and the diaphragm depressed. TTN often resolves spontaneously within 
1-2 days, but some infants may need oxygen therapy and nCPAP. TTN has not been 
associated with any long-term complications.45-47 
 
Respiratory distress syndrome (RDS) 
RDS is a common complication from preterm birth and incidence is inversely related to 
gestational age at birth. RDS is mainly caused by surfactant deficiency. Without 
surfactant, surface tension in the alveoli is high and lung compliance low. As a result, 
hyaline membranes are formed followed by alveolar inflammation. Onset of RDS is 
rapid, usually within a few hours after birth. Typical signs are tachypnea, grunting, and 
intercostal retractions. Need for oxygen and respiratory efforts increase the first 24-36 
hours. The x-ray film shows diffuse atelectasis, air bronchogram and “ground glass” 
pattern. Treatment for RDS includes supplemental oxygen, nCPAP, mechanical 
ventilation and administration of exogenous surfactant. Typically, RDS improves after 
2-3 days but death from progressive hypoxia and respiratory failure can occur.  Severe 
RDS may also be a precursor of chronic lung disease or BPD. Surfactant therapy 
increases survival and decreases risk of pneumothorax and BPD. After the introduction 
of antenatal prophylactic steroid treatment, many cases of RDS have been prevented.48 
Antenatal steroid treatment induces production of surfactant and is currently 
recommended in Sweden when delivery is expected before 32+6 gestational weeks.45,47-
51 
 
Pneumothorax/Pulmonary Interstitial Emphysema (PIE) 
Leakage of gas from the airways into the pulmonary interstitial space is mostly seen as 
a complication from ventilator therapy. If the gas diffuses into the pleura, it causes 
pneumothorax, which may need active drainage. Although rare in moderately preterm 
infants, pneumothorax is the most common cause for sudden deteroriation during 
ongoing ventilator treatment.45 
 
Hypoglycemia 
Blood glucose levels in the newborn infant normally decrease immediately after birth 
but are usually restored within hours. Severe or long-lasting hypoglycemia may cause 
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brain damage. The definition of hypoglycemia varies but is in Sweden defined as a 
plasma glucose level <2.6 mmol/L. Symptoms include jitteriness, irritability, feeding 
difficulties, hypotonia, apnea, bradycardia or seizures but clinical signs can also be 
absent, especially in preterm infants. Risk factors for hypoglycemia include asphyxia, 
hypothermia, respiratory distress, diabetic disease in the mother, fetal growth restriction 
and preterm birth. Infants at risk are treated with early feeding or intravenous fluids and 
monitored with repeated plasma glucose determinations. In severe or symptomatic 
hypoglycemia, intravenous glucose is provided.45,47  
 
Bacterial infections 
Exposure to microorganisms can be transplacental, ascending, intrapartum and/or 
postnatal. Systemic infections in the neonatal period are subdivided into two groups 
according to the time of onset: early onset (within 2 days of postnatal age) and late 
onset (>2 days of postnatal age). Early onset infections are acquired prior to or during 
delivery and are dominated by microorganisms such as group B streptococci, 
enterococci and gramnegative bacteria. Septicemia progresses rapidly if antibiotic 
treatment is not initiated in time. Predisposing factors are prolonged rupture of 
membranes, maternal urinary tract infection and prematurity. In late onset infections 
among preterm infants, nosocomial infections with coagulase-negative staphylococci 
dominate but staphylococcus Aureus, enterobacteriae and Klebsiella species may also 
occur. Clinical signs of late-onset systemic infections are usually subtle, with 
irritability, pallor, feeding difficulties, unresponsiveness, jaundice, apneas and/or 
tachypnea. Antibiotic treatment is given on wide indications before bacterial infection 
can be excluded. Among suspected cases, only 15-20% are later confirmed by a 
positive blood or cerebral fluid culture.45,47   
 
Patent Ductus Arteriosus (PDA) 
In the fetus, the ductus arteriosus connects the pulmonary artery with the aorta, 
permitting oxygenated blood from the placenta to by-pass the lungs in favor of other 
internal organs. After term birth, the ductus arteriosus rapidly closes as a result of 
increased PaO2 and decreased circulating prostaglandin levels. After preterm birth, the 
ductus arteriosus can sometimes persist. The hemodynamical effects are evaluated by 
echocardiography. If a PDA becomes hemodynamically significant and symptomatic, 
treatment with nonselective cyclooxygenase inhibitors (indometacin or ibuprofen), 
which inhibit prostaglandin synthesis and induce ductal constriction, can be indicated. 
Should medical treatment fail or if it is contraindicated, surgical ligation of the PDA 
can be performed.45,47,52  
 
Persistent Pulmonary Hypertension of the Newborn (PPHN) 
As the newborn infant starts breathing, pulmonary vasodilation occurs and pulmonary 
blood flow increases many-fold. If this circulatory transition fails or cannot be 
sustained, the infant may suffer from PPHN. Symptoms usually show early, before 12 
hours of age. Clinical signs are severe hypoxia, a normal x-ray film, right-to-left 
shunting of blood seen on echocardiography in the absence of congenital cardiac 
abnormality. PPHN is often secondary to other morbidities, such as RDS, septicemia, 
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meconium aspiration or asphyxia. Treatment with nitric oxide - a potent and selective 
pulmonary vasodilator - is usually effective.45,47   
 
Hyperbilirubinemia 
Neonatal jaundice affects approximately two thirds of newborn infants in their first 
week of life. It is usually a physiological condition with a benign course but can signal 
underlying infection, metabolic or hemolytic disease. Unconjugated bilirubin 
accumulates in newborn infants as a result of high turnover of red blood cells, low 
glucuronosyl transferase activity in the liver and high enterohepatic recirculation. 
Severe neonatal hyperbilirubinemia may lead to irreversible brain damage, kernicterus, 
as high levels of unconjugated bilirubin are neurotoxic. Phototherapy is the treatment of 
choice for hyperbilirubinemia exceeding 150-250 µmol/L in moderately preterm 
infants, whereas exchange transfusion may be considered, to quickly decrease higher 
serum bilirubin in severe cases. Kernicterus in very-moderately preterm infants is 
nowadays extremely rare although this feared complication has been reported to re-
occur in near-term and term infants discharged early without follow-up.45,47,53-55   
  
Intraventricular Hemorrhage (IVH) 
Approximately 20-25% of all infants with a birth weight lower than 1,500 g are 
diagnosed with IVH and the vast majority are born before 32 weeks of gestation.  
IVH is graded I-IV according to severity, where grades III-IV are associated with 
significantly increased risks for adverse neurodevelopmental outcome. The etiology 
of IVH is complex and involves hypoxia, hypotension, ventilation disturbances 
and/or acidosis. The highest risk of IVH is within the first 24-48 hours after birth and 
by the end of the first postnatal week, most cases with IVH have been diagnosed. 
Given the increasing incidence of IVH at lower gestational ages, preterm infants with 
a GA <32 weeks are screened with repeated cranial ultrasonography.45,47,56  
 
Periventricular leukomalacia (PVL) 
PVL refers to white matter injury of the neonatal brain and is more common after 
preterm birth. PVL is initiated by ischemia and/or inflammation, with resulting cellular 
toxicity. White matter injury can be either focal or diffuse. In a Swedish study of 
extremely preterm infants, 14% had moderate or severe white matter changes on 
cerebral magnetic resonance imaging-examinations at term-equivalent age.57 White 
matter injury is associated with increased risks for cognitive and neurological 
impairment in later life.45,47,58 
 
Necrotizing enterocolitis (NEC) 
NEC is a rare but potentially dangerous complication of prematurity. Its etiology is still 
largely unknown but three predisposing factors have been suggested: decreased 
oxygenation of the gut, invasion of pathogenic bacterial flora and enteral feedings as 
energy substrate. The disease is characterized by acute inflammation of the intestinal 
wall, necrosis, perforations and septicemia. Clinical signs include a distended abdomen 
and blood in the stools. Feeding with human milk decreases risk of NEC and is thought 
to promote colonization of the intestines with protective lactobacilli and 
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bifidobacterium species. Accordingly, enteral administration of probiotics has been 
suggested as a promising intervention to prevent NEC in preterm infants.45,47,59  
 
Retinopathy of prematurity (ROP) 
ROP is a well-known complication from unlimited oxygen supplementation after 
preterm birth, characterized by abnormal vascular growth in the retina which may lead 
to visual impairment or even blindness. In Sweden, all preterm infants born at 32 
gestational weeks or less, are routinely screened for ROP. Treatment of ROP with 
diode laser photocoagulation is effective and reduces the risk of retinal detachment and 
visual impairment.45,47,60 
  
Bronchopulmonary dysplasia (BPD) 
Chronic lung disease or BPD is the most common long-term complication from very 
preterm birth. The disease is histologically characterized by fewer alveoli and abnormal 
structure of pulmonary microvasculature.  BPD is clinically defined as need for oxygen 
supplementation at 28 days of postnatal age (mild form) or at 36 weeks of 
postmenstrual age (moderate form) or need for ventilator at 36 weeks gestational age 
(severe form).61 Etiological risk factors include prenatal inflammation, preeclampsia, 
fetal growth restriction, preterm birth and RDS, which all contribute to defect 
alveolarization and microvascular development. Strategies for prevention and treatment 
include early nCPAP, mechanical ventilation with permissive hypercapnia, optimized 
nutrition including vitamin A supplementation and surfactant treatment in cases with 
RDS. An increased airway resistance and hyperreactivity of the lung are problems that 
can linger into childhood, adolescence and even adult ages.45,47,62  
 
2.5 THE MODERATELY PRETERM INFANT 
2.5.1 Epidemiology 
The rate of moderately preterm birth according to the definition used in these studies 
(birth at 30+0 – 34+6 gestational weeks) is approximately 2%, or 2,200 infants in 
Sweden each year (3.9% in the US63). The majority of infants survive their neonatal 
period and there are today about 36,000 Swedish citizens under 18 years of age that 
were born moderately preterm.  
 
Moderately preterm infants face substantially higher risks for adverse neonatal outcome 
than more mature infants.64-66 In US neonatal units, the moderately preterm infants have 
been reported to account for 27-38% of neonatal unit admissions.67   
 
2.5.2 Maternal, pregnancy and delivery characteristics 
Moderately preterm birth has the same etiology as preterm birth in general (section 
2.3.3.), but risk factors are differently distributed. In a population-based Finnish 
study,68 the most important risk factors for birth at 32-33 gestational weeks were, in 
multivariate analyses, multiple birth, followed by elective Cesarean section, 
primiparity, IVF and smoking. Maternal age did not affect risk of preterm birth in this 
cohort whereas in a Swedish population-based study,69 maternal age of more than 34 
years was a risk factor for moderately preterm birth. Smoking is a preventable risk 
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factor for preterm birth at 32-36 gestational weeks, and is there is a dose-response 
relationship between smoking and preterm birth, especially spontaneous preterm 
birth.70  
 
In our cohort of 4,343 moderately preterm and 467,965 late preterm to term singletons 
born in Sweden in 2004-2008 (Paper IV), maternal, pregnancy and delivery 
characteristics were investigated (unpublished data, Table 1). Significant risk factors 
for moderately preterm birth compared to late preterm to term birth in univariate 
analysis were: maternal overweight before pregnancy, self-reported smoking in early 
pregnancy, maternal chronic disease (asthma was the most common diagnosis), assisted 
conception, preeclampsia, preterm premature rupture of membranes, clinical 
chorioamnionitis and Cesarean delivery. Maternal age did not significantly affect risk 
of moderately preterm birth and multiparity protected against moderately preterm birth 
in univariate analysis. 
   
Table 1. Maternal and pregnancy characteristics and obstetrical interventions in moderately 
singleton preterm infants compared to late preterm to term infants, univariate analysis. 
 Late Preterm to 
Term Infants  
(35-41 weeks) 
(N = 467,629) 
Moderately 
Preterm Infants 
(30-34 weeks) 
(N= 4,679) 
 
Odds Ratio 
 
(CI) 
 n % n % OR CI 
Maternal Characteristics       
Maternal age 
<25 
25-29 
30-34 
35- 
 
65,312 
132,416 
175,946 
93,954 
 
14 
28 
38 
20 
 
678 
1,329 
1,552 
1,120 
 
14 
28 
33 
24 
 
1.0 
1.0 
0.8 
1.1 
 
(ref) 
0.9-1.1 
0.8-0.9 
1.0-1.3 
Parity 
Primipara 
Multipara 
 
181,702 
285,927 
 
39 
61 
 
2,639 
2,040 
 
56 
44 
 
1.0 
0.5 
 
(ref) 
0.5-0.5 
BMI 
≤24.9 
25.0-29.9 
≥30 
 
274,042 
101,600 
37,632 
 
66 
25 
9.1 
 
2,395 
943 
527 
 
62 
24 
14 
 
1.0 
1.1 
1.6 
 
(ref) 
1.0-1.1 
1.5-1.8 
Smoking at admission 32,841 7,6 379 10 1.4 1.2-1.5 
Chronic disease 38,765 8.3 501 12 1.4 1.3-1.6 
Pregnancy       
IVF 18,135 3,9 235 5.4 1.4 1.3-1.6 
Preeclampsia 7,649 1.6 777 18 13 12-14 
Preterm premature rupture of membranes 4,557 1.0 1,289 30 43 41-47 
Chorioamnionitis 321 0.1 56 1.3 18.8 14-25 
Mode of delivery       
Vaginal delivery 426,740 91 2,326 50 1.0 (ref) 
Cesarean section after onset of labor 18,464 4.0 1,878 40 18.6 18-20 
Cesarean section before onset of labor 18,185 3.9 292 6.2 2.9 2.6-3.3 
Cesarean section, unspecified 4,240 0.9 183 3.9 7.9 6.8-9.2 
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2.5.3 Neonatal outcomes 
In contrast to studies of very or extremely preterm infants,14,71 previous studies in 
moderately preterm infants are not population-based,67,72,73 have studied cohorts older 
than 10 years,72-74 provide no gestational age specific data67,73-75 or present only a 
limited number of morbidity measures.73,74 In addition, several studies of moderately 
preterm infants have focused on differences in morbidity between infants born near-
term or at term, 72-74 whereas the neonatal outcomes at the crossroads of moderately 
preterm infants are less well established. Thus, there is a lack of contemporary large 
population-based studies with detailed and gestational age-specific data on neonatal 
morbidity and risk factors for complications after moderately preterm birth.76  
 
Morbidity and interventions in infants born at 30-34 gestational weeks have previously 
been investigated in a US study of 1,250 infants born in 2001-2003 where Escobar et 
al. looked at key in-hospital outcomes and readmissions.67 They found rates of <1% of 
major neonatal morbidities, such as NEC, IVH and ROP among surviving infants. 
Pneumothorax was seen in 1.6%, BPD (defined as oxygen use at 36 weeks GA) in 
3.2%, and sepsis/meningitis in 2.4% of infants. Within this group of moderately 
preterm infants, 46% were treated with ventilator and 19% were treated with nCPAP 
only. Surfactant was administered to 25% and antenatal steroids to 66%. 
Approximately half the infants were discharged before 36 weeks’ gestational age. 
Readmissions to hospital care within three months occurred in 11%, predicted by 
male sex and chronic lung disease. Escobar et al concluded that moderately preterm 
infants experience substantial neonatal morbidity which deserves more research. 
 
Kirkby et al. performed a study of 4,932 infants with a GA of 32-34 weeks, born in the 
US between 2001 and 2004.77NEC and severe IVH were found in less than 1% of the 
infants, bacterial sepsis in 1-3.5%, PDA in 2-5.5%, chronic lung disease (defined as 
need for oxygen therapy at 28 days of life) in 0.5-3.5% (higher rates at lower 
gestational ages). As in the study by Escobar, mechanical ventilation or nCPAP was 
common (42%). Kirkby et al. concluded that moderately preterm infants constitute a 
large proportion of neonatal resource use, are subjected to increased morbidity and that 
it would be important to learn more of the characteristics of this group of infants.  
 
2.5.4 Long term morbidity 
Long-term follow-up of moderately preterm infants have shown poor school 
performance and an increased risk of enrollment in special education programs as 
compared to term infants.78 In addition, subjects born moderately preterm have lower 
IQ and a higher risk of attention and behavior problems,79 lower cognitive test results80 
and even increased hazard ratios for cerebral pares, developmental delay/mental 
retardation and seizures.64 These reports strongly suggest an impact of moderately 
preterm birth on brain development. However, in an Australian study, there were no 
differences in socioeconomic status (SES), psychological functioning and health related 
quality of life in adulthood among 126 subjects born at a mean gestational age of 34 
weeks at birth as compared to term controls.81 
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The first Swedish generation of infants born preterm in the modern era of neonatal care 
has now become young adults. Population-based studies on their long-term outcomes 
show high risks for impairment and disability in adulthood,4 in-hospital care for 
psychiatric disease,3 prescription of inhaled corticosteroids82 and Attention Deficit 
Hyperactivity Disorder (ADHD) in school-age.83  
 
To summarize, the group of moderately preterm infants seem to be at considerable 
risk not only for acute neonatal morbidity, but also for long term adverse health 
effects. 
 
2.6 RESEARCH TOOLS FOR PERINATAL EPIDEMIOLOGIC STUDIES 
2.6.1 The Swedish personal identification number 
Every Swedish citizen is provided with a unique personal identification number at birth 
or immigration, consisting of birth date (yymmdd) followed by a sex-specific 
individual three-digit code and a one-digit check number. The personal identification 
number is used in all situations that require identification of an individual, for example 
in all contacts with the medical care system and in writing patient’s journals.84 
  
2.6.2 Swedish Medical Birth Register (MBR) 
History and purpose 
The Swedish Medical Birth Register was started in 1973, with the purpose to evaluate 
and improve the health of pregnant women and newborn infants by collecting data on 
perinatal factors. The registry is owned by the Swedish National Board of Health and 
Welfare, Centre for Epidemiology. Participation in the register is nation-wide and 
mandatory, thus, the individuals have no right to deny registration.  
 
Contents 
Mothers are identified by the Swedish personal identification number and the infant’s 
identification number is linked to the mother’s. The registry contains data on social 
factors, maternal history, pregnancy, delivery and infant. The data source is 
standardized individual obstetric and pediatric forms that are completed and sent to the 
register for the large majority of all Swedish births.85  
 
Quality 
The quality of the Swedish Medical Birth Register has been evaluated and validated 
against original medical journals three times.86,87 A more detailed English summary on 
contents and quality of included variables can be found at the webpage of the Swedish 
National Board of Health and Welfare.87 Records have been found missing in 
approximately 1.4% of all births. For estimation of gestational length, the majority of 
women in the last decades have undergone ultrasound scanning.6 The Birth Register 
uses a hierarchical model to estimate gestational age, which in essence first uses 
information on ultrasound estimation, then the last menstrual period, and thereafter uses 
stated information on length of gestation as recorded at the delivery ward. Many 
variables, such as maternal identification number, birth weight, date of admission to 
delivery unit and discharge date, hospital codes, multiple birth status and infant sex 
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have high quality. Use of tobacco products in early pregnancy had 4-9% of missing 
values. Other variables have a larger proportion of missing data, such as maternal drug 
use and infants ICD-10 diagnoses87 and reporting of ICD-diagnoses has been found to 
differ between hospitals.86  
 
2.6.3 Swedish Perinatal Quality Register (PNQ) 
History 
PNQ was created in 2000 as a local hospital register collecting data from infants that 
had been admitted to the neonatal unit. Soon, the register grew to include more clinics 
and by 2004, 21 out of 34 Swedish neonatal units reported all their patients to PNQ. 
From January 2008 and forward, PNQ contains data on all patients from all Swedish 
neonatal units.   
 
Purpose 
The main purpose is to evaluate quality of neonatal care in Sweden on a continuous 
basis. The database is located on the internet, which facilitates both reporting and 
searching for data. Open-access reports on some quality-related outcomes are regularly 
published online. Clinics have access to the database to see and analyse results and 
outcomes of their home clinic patients. In addition, it is possible to request a specified 
unidentified dataset from the PNQ for research purposes.    
 
Contents 
PNQ contains information on approximately 60,000 newborn infants (December 2010). 
The register holds detailed data on maternal characteristics, pregnancy, delivery, acid-
base status, neonatal resuscitation, hospital stay, breathing, mechanical ventilation and 
nCPAP, infections, treatment of infections, neurology, specified pharmacological 
treatment, treatment with hypothermia, other specified morbidity, other specified 
interventions, diagnoses (including congenital malformations) classified by ICD-10, 
discharge data, and detailed data on deceased infants.  
 
Quality 
Diagnostic criteria for all morbidity measures are predefined to avoid variation in 
diagnoses between centres or users. The data is obtained from standardized 
questionnaires prospectively filled out by physicians during neonatal care and at 
hospital discharge of each infant. The questionnaires are transmitted to an electronic 
form and into the database. So far, the PNQ Register has not been properly validated or 
evaluated. 
 
2.6.4 Comparison of MBR and PNQ  
Individually linking information from MBR and PNQ, using the Swedish personal 
identification number, creates a powerful, population-based tool for studies on perinatal 
epidemiology. The Medical Birth Register contributes with detailed and valid data on 
the mother and pregnancy and the PNQ brings a large amount of data on the neonatal 
period for all infants who have been admitted to neonatal care. The similarities and 
discrepancies in data between the two registers have not previously been described. 
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We have compared the correspondence of some variables that can be found in both 
registries. Information on 4,679 singleton moderately preterm infants born in 2004-
2008 was collected from PNQ and linked to the Medical Birth Register. Data on infant 
characteristics and diagnoses was extracted and compared between the registers. 
 
Infant sex 
Reports on sex correlated in 99% of the infants. 
 
Birth weight 
The correlation of birth weight between the registers was good (r=0.97, p < 0.001). 
 
Gestational age 
The study group was defined by gestational age in PNQ (30-34 weeks). Gestational age 
was similar in the two registers in 81% of the infants. This finding is consistent with a 
previous validation of MBR and original journals.87 The correlation coefficient was 
0.83 (p<0.001), but the range of GA in MBR was 27 to 40 gestational weeks. The 
majority (91%) of the misclassified GA data differed only one week from GA in PNQ. 
Of the misclassified GA, 84% were classified as one week higher GA in MBR than in 
PNQ. It is not possible to determine which register that has the more accurate data on 
gestational age without looking into original records and using information from 
original ultrasound estimations of pregnancy length. 
 
When comparing gestational age in days, the correlation between the registers was 
improved. Mean gestational age was 233 (SD 9.4) in PNQ and 234 (9.8) in MBR. The 
25th, 50th and 75th percentiles only differed 1 day between the registers and the 
correlation coefficient was 0.92 (p < 0.001).  
 
Neonatal diagnoses and interventions 
For TTN, RDS, BPD, nCPAP and ventilator therapy, calculations on sensitivity and 
specificity were performed, given the hypothesis that PNQ would have the most 
accurate data on neonatal diagnoses and interventions. Definitions of sensitivity and 
specificity are presented in textboxes below. 
 
 
 
 
 
 
 
 
Results are presented in Table 2. The quality of registration of neonatal diagnoses in 
MBR shows considerable variation when compared to PNQ. Sensitivity and specificity 
of TTN and RDS are high, whereas BPD, nCPAP and ventilator therapy have low 
sensitivity but very high specificity.   
Sensitivity = 
True positive 
(True positive + false negative) 
 
Pos PNQ 
(Pos PNQ + Pos PNQ – Pos PNQ&MBR) 
Specificity =  
True negative 
(True negative + false positive) 
 
Neg PNQ 
(Neg PNQ + Pos MBR - Pos PNQ&MBR) 
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Table 2. Sensitivity and specificity of reported diagnoses and interventions in 4,679 infants in 
the Swedish Medical Birth Register (MBR) as compared to the Swedish Perinatal Quality 
Register (PNQ) 
 Positive 
cases in 
PNQ & MBR 
(n) 
Positive 
cases in 
MBR 
(n) 
Positive 
cases in 
PNQ 
(n) 
Sensitivity Specificity 
TTN 479 636 663 96% 96% 
RDS 526 593 630 94% 98% 
BPD 28d 
BPD 36w 
13 
11 
30 
30 
57 
47 
68% 
73% 
99% 
99% 
nCPAP 405 432 2,034 56% 99% 
Ventilator 59 68 275 57% 100% 
 
 
2.7 HEALTH ECONOMICAL ASPECTS 
2.7.1 Costs of neonatal care in Sweden 
Budgets and money is of central concern for health policy decisions. The allocation of 
resources must be directed towards areas that are necessary but also cost-effective. 
Evaluations of consequences, effectiveness, utility and benefit of specific actions can 
guide decisions toward this goal. Results of these evaluations affect the routines and 
methods in every-day work at the health care units.88 For example, new pharmaceutical 
treatments can be more expensive than the older medication but may also have less side 
effects or better results in long-term evaluations and thus cost less in the end. Building 
an organized Home Care unit with trained staff, vehicles and equipment is expensive 
but as more infants can be discharged earlier from the neonatal unit, costs for overall 
health care may still decrease.  
 
A simplified approach to study costs of neonatal care would be to calculate average 
length of stay and multiply by the average daily cost at the neonatal unit. In addition to 
this, other direct costs such as medications, investigations, use of equipment and 
specially trained staff etc. must be added to come closer to an estimation of the true 
costs. Indirect costs falling on budgets outside the hospital should also be added, such 
as travels to and from the hospital, loss of production, sick/maternity pension for 
parents and future readmissions of the infant. The third category is intangible costs, 
which are much more difficult to estimate. They refer to the costs of suffering and loss 
of quality of life after a disease or treatment. Methods to calculate intangible costs use 
quality adjusted life years (QALY) as an approximation of loss or gain of quality of life 
during a specified number of years.88  
 
An American study from 200777 found that infants of 32-34 gestational weeks 
represented 25% of admissions to neonatal units. The average cost per case was 31,000 
USD, representing 22% of total neonatal unit costs. The conclusion was that 
moderately preterm birth adds a large contribution to neonatal costs and that it may be 
possible to optimize care to decrease use of resources. 
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2.7.2 Impact of length of hospital stay on neonatal costs 
In a Swedish evaluation of costs of neonatal care and length of hospital stay in preterm 
infants born 1998-2001, the correlation between gestational age and costs is clearly 
negative. The preterm infants had a four times longer stay compared to term infants. 
Length of hospital stay corresponded well to the estimated costs of care, calculated by 
measures of charge.89  
 
At Karolinska University Hospital in Stockholm, Sweden, patients from other Swedish 
health regions are sometimes admitted for neonatal care. The patient’s home health care 
region pays Karolinska University Hospital for the hospital stay and the price can be 
used as an approximation of the average costs for neonatal care. In 2011, it has been set 
to 15,244 SEK (2450 USD)/24 hours for neonatal intensive care of infants >28 
gestational weeks or >1500 g and to 10,712 SEK(1700 USD)/24 hours for neonatal 
care (not intensive care). If ventilator treatment is needed, a cost of 17,510 SEK(2800 
USD)/24 hours is added. 
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3 AIMS 
Determinants of length of hospital stay, contemporary measures of morbidity by 
gestational week and risk factors predicting neonatal morbidity in moderately preterm 
infants have been poorly studied. The overall purpose of this thesis was to fill these 
gaps in knowledge to make neonatal care more effective, and to improve short- and 
long-term outcomes for moderately preterm infants.  
 
The specific aims of the included studies were: 
 
• To determine trends in length of hospital stay for moderately preterm infants 
during the last twenty years and to identify factors that contributed to changes 
over time (Paper I);    
 
• To determine postmenstrual age at hospital discharge for moderately preterm 
infants and its relation to perinatal risk factors and to organization of care 
(Paper II); 
 
• To determine the gestational age specific risks for neonatal morbidity and use of 
interventions in infants born moderately preterm (Paper III); and 
 
• To investigate risks of respiratory diseases in moderately preterm infants and to 
identify maternal, obstetric and neonatal risk factors for acute respiratory 
morbidity (Paper IV). 
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4 METHODS 
 
4.1 STUDY COHORTS 
All papers in this thesis are based on infants born moderately preterm, at 30+0 to 34+6 
gestational weeks and days, and in Sweden. Ethical approval was obtained from the 
regional ethical vetting board prior to the initiation of all studies. 
 
The characteristics of the study cohorts are presented in Table 3. Paper I includes a 
longitudinal, in part historical, population and Papers II-IV are contemporary but with 
different exclusion criteria, which creates four different cohorts of moderately preterm 
infants.  
 
The mean values of maternal age, gestational age and birth weight were approximately 
equal in the four study populations, except for a decrease in maternal age and a small 
increase in birth weight in Paper IV, probably due to the exclusion of multiple births. 
Mean maternal age increased from 29.7 to 32.2 between 1983 and 2002 in Paper I. The 
rates of multiple birth and SGA were robust. A low Apgar score indicating asphyxia 
was less common in Paper II, probably as a result of the exclusion criteria. Paper I had 
the same exclusion criteria but there were no infants with malformations or major 
surgery in the original register to exclude and the study population may not be large 
enough to study such rare events as asphyxia. In Papers I-IV, SGA was defined as birth 
weight for gestational age more than 2 SD below the mean according to Swedish 
standards for normal fetal growth of both sexes.90 
 
Table 3. Characteristics of study cohorts in Paper I-IV 
 Paper I Paper II Paper III Paper IV 
Birth years 1983, 1988, 
1993, 1998, 
2002 
2004-2005 2004-2008 2004-2008 
Setting Danderyd 
Hospital 
National data National data National data 
Subgroup Exclusion of: 
malformations, 
major surgery, 
neonatal death  
Exclusion of: 
malformations, 
major surgery, 
neonatal death  
All live births 
included 
 
 
All live born 
singletons 
included 
 
N of included infants 564 2,388 6,674 4,679 
Maternal age* 31 (5.4) 31.2 (5.4) 31.2 (5.4) 30.5 (5.5) 
Multiplets 27%  26% 26% - 
Gestational age* 33.0 (1.3) 32.8 (1.3) 33.1 (1.4) 32.8 (1.3) 
Birth weight* 2,030 (453) 2,086 (476) 2,062 (471) 2,117 (484) 
SGA 12% 13% 13% 13% 
Male sex 52% 52% 54% 56% 
Apgar score 0-3 at 5 
minutes’ age 
1.0% 0.6% 1.0% 1.1% 
*mean (SD) 
 
4.2 DATA SOURCES 
The Perinatal Quality Register has been the primary source of data on participating 
infants in Papers II-IV of this thesis. In addition, Paper I was partly based on 
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prospectively registered data in a local hospital register similar to PNQ, used to 
assemble information on infants born during the years 1983-1998. In Paper IV, 
information on mother, pregnancy and delivery characteristics was added from the 
Swedish Medical Birth Register.  
 
Definition of diagnoses in PNQ 
Diagnostic criteria for all morbidity measures are predefined in the PNQ register to 
avoid variation in diagnoses between centers and/or users (Table 4).  
 
Table 4. Definitions of diagnoses in PNQ 
Diagnose  Definition 
Transient tachypnea of the newborn (TTN) An acute, non-infectious respiratory disorder 
with positive x-ray findings and decreasing 
need for supplemental oxygen therapy in the 
first 24 hours after birth 
Respiratory distress syndrome (RDS) An acute, non-infectious respiratory disorder 
with progressively increasing central 
cyanosis in room air or need for 
supplemental oxygen to maintain PaO2 ≥ 6.6 
kPa in the first 24 hours after birth, and a 
typical x-ray 
Hypoglycemia Plasma glucose < 2.6 mmol/L at a postnatal 
age ≥ 3 h 
Bacterial infection Relevant positive cultures and/or clinical 
criteria for meningitis, septicemia, 
pneumonia, pyelonephritis, osteomyelitis, 
pemphigus, omphalitis or arthritis 
Patent ductus arteriosus (PDA) Requiring medical or surgical treatment 
Hyperbilirubinemia Requiring phototherapy or exchange 
transfusion 
Intraventricular hemorrhage (IVH) Graded in accordance with Papile91 
Periventricular leukomalacia (PVL) In accordance with de Vries92 
Necrotizing enterocolitis (NEC) In accordance with Bell93 
Retinopathy of prematurity (ROP) In accordance with the International 
Classification for Retinopathy of 
Prematurity94 
Bronchopulmonary dysplasia (BPD) Defined as oxygen supplementation at 36 
weeks of gestation 
 
4.3 LENGTH OF HOSPITAL STAY  
In Papers I-II, LOS was calculated in days. However, as LOS for infants born at 30 
gestational weeks is usually longer than for infants born at 34 gestational weeks, and 
because infants born at 34 weeks exceed the infants born at lower gestational weeks in 
numbers, the distribution of LOS in days is skewed. Accordingly, we also used 
postmenstrual age (PMA) at discharge as outcome. This variable was almost normally 
distributed (Figure 6) and similar for infants of all gestational ages. 
 
4.4 PAPER I 
Study design 
To determine longitudinal trends in LOS for moderately preterm infants during the 
last twenty years, a study group was assembled from one of Karolinska University 
Hospital’s neonatal units, located at Danderyd Hospital. Danderyd Hospital is 
situated in the northern part of Stockholm and responds to all deliveries greater than 
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26 gestational weeks. The population of the recruitment area is mostly Caucasian, 
middle to upper class.  
 
A total of 564 moderately preterm infants admitted for neonatal care during five years 
were included: 1983 (n = 51), 1988 (n = 114), 1993 (n = 115), 1998 (n = 148) and 
2002 (n = 154). Exclusion criteria were life threatening malformations (n = 0), 
chromosomal anomalies (n = 0) and death during initial hospitalization (n = 10). Four 
infants were excluded due to incomplete information regarding LOS. In 1983 and 
1988, GA was calculated from menstrual dates, which resulted in an age estimate of 
completed gestational weeks. In the following cohorts, antenatal ultrasound in early 
second trimester was used for GA estimation and was expressed as completed weeks 
and days.  
 
Data collection and analysis 
For the 1983 to 1998 cohorts, data was collected from the local register and hospital 
charts and in the 2002 cohort, from PNQ. Information on maternal age, multiple 
pregnancy, GA, birth weight, infant sex and neonatal morbidity and treatment 
including Apgar score, RDS, nCPAP-therapy, ventilator therapy and BPD was 
collected. Infants treated with intravenous antibiotic therapy were also noted as an 
indicator of infection rate.  
 
All data was initially analyzed separately in the five different cohorts according to birth 
year. LOS in days and PMA were calculated individually and considered as outcomes. 
Infants with LOS >75 days or a PMA at discharge exceeding 42 weeks (>3 interquartile 
distances above the median) were considered as outliers and excluded from statistical 
calculations (n = 6). 
 
4.5 PAPER II 
Study design and population 
This cross-sectional study of LOS in moderately preterm infants in different Swedish 
hospitals was based on data from PNQ. During the years 2004-2005, 21 of 34 neonatal 
units in Sweden reported all their in-patients to the register. We extracted information 
on all moderately preterm infants admitted to these units. Infants with one or more of 
the following diagnoses were excluded: major malformation, (renal n=15, cardiac 
n=126, central nervous system n=5, gastrointestinal n=39, cleft palate n=13, 
miscellaneous n=42), chromosomal anomalies (n=21), major surgery (n=35) or death 
(n=36) during neonatal unit (NU) hospitalization. We also excluded infants with 
missing information on LOS (n=20). After exclusion, 2,388 infants were included in 
the study. 
 
Risk factors and outcomes 
Maternal age, multiple birth, GA, birth weight and sex were considered as potential risk 
factors. Neonatal morbidity was defined according to Table 4.  
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All 21 NUs reporting to the PNQ also responded to a questionnaire concerning 
organization of care. The individual NUs’ identities were blinded to the investigator 
during data collection and analysis. The participating NUs were categorized according 
to unit level I-III.10 Unit size was characterised by numbers of yearly admissions of 
infants with a GA of 30-34 completed weeks (less than 50 or at least 50), facilities for 
co-care of mother and infant, use of NIDCAP, fixed criteria for home discharge, and/or 
home care program. 
 
PMA at discharge was considered main outcome measure and was defined as number 
of days from last menstrual period, corrected for by early second trimester ultrasound in 
all women. To specify the PMA at discharge, the destination at hospital discharge 
(other clinic/hospital, home care or home without support) was investigated. Because 
bottle fed preterm infants have been reported to have shorter hospital stay,95 outcome 
data was stratified and analyzed according to breastfeeding or not.  
 
The purpose of this study was to investigate risk factors for PMA at hospital discharge 
to home. Infants discharged to other clinics (n=125) were therefore excluded from the 
risk factor analyses. Infants with a LOS of 3 interquartile distances above the 75th 
percentile (n=10) were considered outliers and were also excluded from these analyses. 
The final number of infants for statistical analyses was 2,253.  
 
4.6 PAPER III 
Study design and population 
To explore neonatal morbidity and interventions stratified by gestational week, we 
extracted PNQ information on all 6,677 infants born at 30-34 weeks in 2004-2008. 
Three infants born at 31-32 weeks, having birth weights for gestational age > +5.5 SD90 
and 3-5 days length of hospital stay were excluded due to strong suspicion of 
misclassification. After exclusion, 6,674 infants remained in the study group. 
 
Outcomes  
The following neonatal diagnoses were considered as outcomes: TTN, RDS, 
hypoglycemia, bacterial infection, PDA, hyperbilirubinemia, IVH, PVL, NEC, ROP, 
BPD, malformations (specified by ICD-10 codes Q00-Q89), chromosomal 
aberrations (specified by ICD-10 codes Q90-Q99) and death before discharge to 
home. Secondary outcomes were the following treatments and interventions provided 
before or at birth or during the neonatal hospitalization period: antenatal steroids, 
nCPAP, ventilator treatment, surfactant, antibiotics, pharmacological or surgical 
treatment of PDA, and exchange transfusion.  
 
Birth weight standard deviation scores 
Birth weight for gestational age was stratified into the following standard deviation 
groups: <-2; -2 to <-1; -1 to +1; >+1 to ≤+2; and >+2SD. Morbidity outcomes were 
then presented by birth weight for gestational age, which also was stratified and 
presented by GA. 
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4.7 PAPER IV 
Study design and population 
This project was designed as a population-based study of acute respiratory morbidity in 
live born infants in Sweden between 2004 and 2008, with a GA at birth from 30 to 41 
completed gestational weeks. Using information about mothers’ personal identification 
number and infant’s birth date, it was possible to link information from PNQ to MBR. 
In the process of linking the two registers, 318 infants were excluded because of lack of 
reliable identification data. After linkage, 6,362 very to moderately preterm infants (30-
34 weeks) remained in the study group. From the MBR, 472,318 late preterm to term 
infants (gestational age 35-41 completed weeks) born during the same time period were 
identified. We chose to restrict all analyses to single births because neonatal morbidity 
may differ between multiple and singleton born infants and because the reliability of 
identification of same-sex twins was uncertain when the two registers were linked 
together. After exclusion of all multiple births, there were 4,679 very to moderately 
preterm infants and 467,629 late preterm to term infants. 
 
Outcomes and risk factors 
First, we compared risks of respiratory diseases between infants born at 30-34 weeks 
and 35-41 weeks. In these comparisons, information about infant respiratory diseases 
was derived from MBR, using ICD-10. The following diseases were included as 
outcomes: TTN (ICD-10 code P22.8), RDS (ICD-10 code P22.0), pneumothorax and 
PIE (ICD-10 codes P25.1 and P25.0), pneumonia (ICD-10 code P23 and J12-J18), 
meconium aspiration syndrome (ICD-10 code P24.0), PPHN (ICD-10 code P29.3B), 
and BPD (ICD-10 code P27.1). 
 
Second, within the group of moderately preterm infants, we studied risks of the most 
common respiratory diseases, TTN and RDS. In these analyses, data on outcomes was 
obtained from PNQ.  
 
The following possible risk factors for TTN and RDS in the neonatal period were 
included in univariate and multivariate analysis: maternal age (<24; 25-29; 30-34; and 
≥35 years); parity (primiparity and multiparity); body mass index in early pregnancy 
(<25; 25-29; ≥30); chronic disease of the mother (asthma n=321 [7.3% of all mothers to 
very to moderately preterm infants]; renal disorders n=31 [0.7%]; diabetes n=83 
[1.9%]; ulcerative colitis n=36 [1.0%]; systemic lupus erythematosus n=8 [0.2%]; and 
chronic hypertension n=65 [1.5%]), assisted conception (hormonal stimulation of 
ovaries; surgical treatment of infertility; intracytoplasmatic sperm injection and/or other 
form of assisted conception); preeclampsia (including eclampsia); premature rupture of 
membranes before onset of labor (regardless of time to delivery); mode of delivery 
(vaginal delivery; Cesarean section after onset of labor; Cesarean section before onset 
of labor; unspecified Cesarean section); antenatal steroid treatment; SGA status; infant 
sex; Apgar score at 5 minutes’ age (0-3; 4-6; 7-10); and gestational age in completed 
weeks.  
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4.8 STATISTICAL ANALYSES 
Data are presented as means (SD or 95% confidence intervals) or proportions (numbers 
and percent). Student´s t-test and ANOVA were used to compare variables with a 
normal distribution. The Mann-Whitney U-test and Kruskal Wallis test were used to 
compare non-parametric variables. Chi-Square test was used to compare proportions.  
 
In Papers I and II, linear regression analyses were used to evaluate contributions to 
LOS from the neonatal morbidity, hospital level and size, as well as organization of 
care. Covariates with p-values < 0.20 were subsequently entered into stepwise forward 
multiple regression models. In the multivariate model, we included maternal age, 
multiple pregnancy, GA, SGA, sex and neonatal morbidity and studied contributions 
from these risk factors to LOS. Subsequently, data regarding hospital characterization 
were added to the multiple regression models. 
 
In Paper III, logistic regression was used to obtain odds ratios and 95% confidence 
intervals for morbidity outcomes and interventions at 30, 31, 32 and 33 gestational 
weeks as compared to 34 weeks. Because infants were actively screened for some 
morbidity outcomes (IVH, PVL and ROP) when born at 30, 31 and 32 weeks but not 
thereafter, 32 weeks was used as reference and risks at 33 and 34 weeks were omitted 
for these outcomes. Similarly, 32 weeks was used as reference in antenatal steroids 
because it was standard treatment in expected deliveries before 33 weeks but not in 
later gestational weeks.  
 
In Paper IV, risk factors for TTN and RDS were divided into maternal (maternal age; 
parity; BMI; daily smoking in early pregnancy; chronic disease; assisted conception; 
preeclampsia; premature rupture of membranes; and mode of delivery) and infant 
related risk factors (antenatal corticosteroid therapy; SGA status; sex; Apgar score at 5 
minutes’ age; and gestational age). When building the multivariate models, we 
restricted the analysis to either maternal or infant related risk factors. Gestational age 
was found to be the strongest and most robust risk factor for TTN and RDS in all 
analyses and was included in all multivariate models. Accordingly, maternal risk 
factors were adjusted for gestational age and maternal risk factors but not for infant 
related risk factors. Infant related risk factors were adjusted for gestational age in model 
1 and for all infant characteristics in model 2 but not for maternal risk factors. Logistic 
regression was used to obtain odds ratios and 95% confidence intervals in multivariate 
analyses. Effect modification was tested by likelihood ratio interaction test and 
stratification. 
 
A P-value <.05 was considered significant. All analyses were performed with Stata 9.2 
software (Stata-Corp, College Station, Texas). 
 
 
 
 
 28 
5 RESULTS 
5.1 STUDY COHORTS 
Table 5 demonstrates how characteristics among moderately preterm infants compare 
to those of late preterm and term infants in a cohort of singletons born in Sweden 2004-
2008. The risk of being SGA, male, having a congenital malformation and/or an Apgar 
score of 0-3 at 5 minutes’ age were significantly increased in the moderately preterm 
infants as compared to late preterm to term infants.  
 
 Table 5. Infant characteristics in moderately preterm infants compared to late preterm to term 
infants.  
  
Late Preterm to Term 
Infants 
(35-41 weeks) 
(n = 467,965) 
 
 
Moderately Preterm 
Infants 
(30-34 weeks) 
(n = 4,343) 
 
Odds Ratio 
 
(CI) 
 n % n % OR CI
Infant characteristics   
SGA status 7,771 1.7 589 13 8.6 7.8-9.4
Male sex 230,629 49 2,628 56 1.3 1.2-1.4
Congenital malformation 14,783 3 473 10 3.4 3.1-3.8
Apgar < 4 at 5 minutes 427 0.1 52 1.1 13 9.4-17
Gestational age 
30 weeks 
31 weeks 
32 weeks 
33 weeks 
34 weeks 
35 weeks 
36 weeks 
37 weeks 
38 weeks 
39 weeks 
40 weeks 
41 weeks 
 
 
 
 
 
 
5,069 
9,967 
19,370 
78,275 
124,687 
134,718 
95,879 
 
 
 
 
 
 
1.1 
2.1 
4.1 
16 
27 
29 
20
 
382 
560 
732 
1,091 
1,578
 
8.8 
12 
17 
25 
36
 
 
 
5.2 LENGTH OF HOSPITAL STAY 
5.2.1 Length of stay in a longitudinal perspective (Paper I) 
During the five study years, 24,368 deliveries occurred at Danderyd Hospital and a 
total number of 2,958 (2,701 inborn) infants were admitted to the NU. Twenty 
percent of the admitted infants were moderately preterm. Of the total number of bed-
days, moderately preterm infants consumed almost fifty percent (figure 5). 
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Figure 5. Proportions of moderately preterm infants admitted to the neonatal unit and their 
proportion of the total bed-days at the neonatal unit. 
 
 
 
 
Infant morbidity and interventions 
The rates of low Apgar scores and RDS did not differ significantly between the year 
cohorts. During the 20 year study period, antibiotic treatment decreased (p<0.05), use 
of nCPAP increased (p<0.05) and the need for ventilator therapy decreased (p<0.05, 
Pearson Chi-Square test). Transfers between hospitals increased somewhat. In 2002, a 
lower proportion of infants were discharged directly to home (85%), as compared to 
the other year cohorts (mean 94%, p<0.05).  
 
There were no significant differences in perinatal characteristics (birth weight, GA, 
SGA, twinning rate), morbidities (low Apgar score, RDS) or interventions (antibiotic, 
nCPAP and ventilator treatments) among infants that were transferred to other units 
as compared to those discharged directly to home. In addition, infants transferred to 
other units in 2002 did not have any indirect or direct factors suggesting higher 
morbidity (such as lower birth weight, lower Apgar scores, higher frequency of RDS 
or nCPAP treatment), compared to infants transferred to other units in 1983-1998. 
This speaks against the possibility that infants in 2002 were selectively referred to 
other units because of higher morbidity. 
 
Length of stay 
The overall LOS for moderately preterm infants was 24 (13) days and postmenstrual 
age at discharge was 36.6 (1.5) weeks. In 2002, LOS and postmenstrual age at 
discharge were significantly lower than in the earlier cohorts (p<0.05). Excluding 
infants transferred to other units did not alter these findings (Table 6).   
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Table 6. Length of hospital stay in moderately preterm infants according to year of birth 
 1983 1988 1993 1998 2002 
All infants (n = 564)      
   LOS, days  26 (13) 25 (11) 28 (12) 26 (13) 17 (13)* 
   GA at discharge,     
   Weeks 
37.2 (1.8) 36.8 (1.2) 37.1 (1.2) 36.6 (1.5) 35.8 (1.4)* 
      
After exclusion of 
infants transferred to 
other units (n = 513) 
     
   LOS, days 28 (10) 26 (11) 29 (12) 26 (12) 19 (13)* 
   GA at discharge,  
   Weeks 
37.7 (1.2) 36.9 (1.1) 37.1 (1.2) 36.7 (1.2) 36.0 (1.2) 
      
Healthy, inborn 
singletons discharged 
to home  
(n = 179) 
     
   LOS, days 28 (11) 23 (8) 24 (10) 20 (10) 14 (7)* 
   GA at discharge,  
   Weeks 
37.9 (1.3) 36.7 (1.0) 36.9 (1.1) 36.5 (1.5) 35.8 (1.0)* 
LOS = Length of stay, GA = Gestational Age 
Mean (SD) values 
* = p < 0.05 versus all other year cohorts. 
 
Risk factors associated with significantly longer LOS were in multivariate regression 
analysis: twin birth (+2.1 days, p<0.001), SGA (+1.6 days, p=0.008), and nCPAP 
treatment (+1.7 days, p<0.001). Factors associated with shorter LOS were: birth year 
2002 (-4.2 days, p<0.001), gestational age (-5.2 days/week increase in GA, p<0.001) 
and transfer to other unit (-5.9 days, p<0.001). Taken together, these variables 
explained 55% (r2 = 0.55, p<0.001) of the variation in LOS. Restricting the analysis 
to healthy (no ventilatory support) inborn singletons discharged to home, the change 
in LOS over the years became more evident: it decreased from 28 (11) days in 1983 
to 14 (7) days in 2002 (p<0.05). 
 
Risk factors associated with significantly higher PMA (in weeks) at discharge were: 
GA (+0.18 weeks, p<0.001), twin birth (+0.27 weeks, p<0.001) and nCPAP treatment 
(+0.23 weeks, p<0.001). Factors associated with lower PMA at discharge were: birth 
year 2002 (-0.64 weeks, p<0.001) and transfer to other unit (-0.88 weeks, p<0.001). 
Taken together, 29% (r2=0.29, p<0.001) of the variation in PMA could be explained 
by these variables. 
 
5.2.2 Length of hospital stay – a multicenter survey (Paper II) 
Maternal and neonatal risk factors and PMA at discharge 
The mean (±SD) value of PMA at hospital discharge was 36.9 (1.7) weeks. 
Postmenstrual age at discharge had an approximately normal distribution with a median 
value of 36.7 (range 30.3 to 46.7) weeks (Figure 6). Female and male infants had the 
same mean value of PMA at discharge (36.9 weeks).  
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Figure 6. Distribution of postmenstrual age (days) at discharge. 
 
 
In both uni- and multivariate analyses, a higher PMA at discharge was associated with 
high (>35 years) maternal age, multiple gestation, SGA and neonatal morbidity.  
 
Low GA at birth was associated with a higher PMA at discharge in univariate analysis 
but not after controlling for neonatal morbidity. Thus, the effect of GA on PMA at 
discharge could be explained by higher neonatal morbidity in more immature infants. 
Maternal and neonatal risk factors could only explain 13% (R2=0.13, p<0.001) of the 
total variation in PMA at discharge (Table 7). 
 
Table 7. Maternal, neonatal and hospital characteristics in moderately preterm infants and their 
significance for postmenstrual age (PMA) in days at hospital discharge to home (n = 2,253). 
 Univariate analyses 
β = regression coefficient   
(p-value) 
Multivariate Analysis 
β = regression coefficient   
(p-value) 
Maternal and pregnancy 
data 
  
Maternal age ≥35 3.08 (<0.001) 2.39 (<0.001)
Maternal age 25-29 -1.74 (<0.001) -0.75 (ns)
Multiple birth 4.54 (<0.001) 4.16 (<0.001)
Gestational age at birth -0.74 (<0.001) -0.26 (ns)
Small for gestational age 6.28 (<0.001) 5.42 (<0.001)
Neonatal morbidity 
Respiratory distress syndrome 4.88 (<0.001) 3.67 (<0.001)
Infection 3.69 (<0.001) 2.27 (0.001)
Hypoglycemia 2.00 (0.001) 1.87 (0.001)
Hyperbilirubinemia 1.52 (<0.001) 1.07 (0.010)
Severe neonatal morbidity* 12.7 (<0.001) 9.70 (<0.001)
Hospital characteristics 
Level 3 neonatal unit -2.26 (<0.001) -1.47 (0.001)
Fixed discharge age criteria 4.66 (<0.001) 3.27 (<0.001)
Small unit 0.43 (ns) -
Domiciliary care -9.76 (<0.001) -9.62 (<0.001)
Intercept (days) 263.8 (p<0.001)
R2 in total multivariate model=0.21 and without hospital characteristics = 0.13. A p-value > 0.05 was 
considered non-significant (ns).  
*Severe neonatal morbidity include infants with one or more of the following diagnoses: ROP grade 3-4, 
IVH grade 3-4 or BPD. 
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Organization of care and PMA at discharge 
The result of the questionnaire that was answered by all 21 neonatal units included in 
Paper II is presented in figure 7.  
 
Figure 7. Results of a survey to the participating neonatal units regarding organization of care 
for moderately preterm infants. 
 
 
 
 
 
The mean PMA at discharge differed up to 2 weeks between hospitals (Figure 8). We 
found an overrepresentation of multiplets (27 vs 22%, p=0.03) and infants with 
hypoglycemia (19 vs. 15%, p=0.02) in hospitals with medium to high PMA at 
discharge as compared to hospitals with low PMA at discharge. There were no other 
statistically significant differences in perinatal risk factors between low and medium-
high PMA hospitals. 
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Figure 8. Differences in postmenstrual age at discharge between neonatal units 
 
 
 
Comparing hospitals with low to hospitals with medium-high PMA at discharge, level 
3 neonatal units, larger hospitals and hospitals without fixed criteria for discharge were 
overrepresented in the lower tertile for PMA at discharge (Table 8). These differences 
were not statistically significant, possibly due to limitations in statistical power. 
Practice of co-care of mother and infant, NIDCAP in use and available organized home 
care did not differ between hospitals with low as compared to medium-high PMA at 
discharge.  
 
Table 8. Organization of care for moderately preterm infants in hospitals with low (n=7) as 
compared to medium-high (n=14) postmenstrual age (PMA) at discharge to home  
 Low PMA  
at discharge* 
Medium-high PMA 
at discharge** 
P-
value 
Level 3 Hospital 3/7 (43 %) 2/14 (14 %) Ns 
Unit size:≥ 50 infants/year 4/7 (57 %) 6/14 (43 %) Ns 
Co-care mother-infant‡ 5/7 (71 %) 8/14 (57 %) Ns 
NIDCAP in general use‡ 3/6† (50 %) 6/14 (43 %) Ns 
Fixed criteria for discharge 0/7 3/14 (21 %) Ns 
Domiciliary Care available‡ 3/7 (43 %) 8/14 (57 %) Ns 
Mean birth weight (g) 2087 (480) 2090 (466) Ns 
Mean weight at discharge (g) 2450 (395) 2619 (447) <0.001 
Values are numbers of hospitals (proportions) or mean values (SD). P-values were calculated 
by chi-square test (proportions) or t-test (mean values) and considered non-significant (ns) if 
>0.05. 
*Low PMA at discharge consisted of 7 hospitals with a low mean value of PMA at discharge (n 
of infants = 781), ranging from 35.7 to 36.6 postmenstrual weeks 
**Medium-high PMA at discharge consisted of 14 hospitals with a medium or high mean value 
of PMA at discharge (n of infants = 1472), ranging from 36.7 to 37.6 postmenstrual weeks. 
†One hospital in the study group did not report on NIDCAP use. 
‡Although item could be provided, the number of infants actually receiving each item could be 
lower.  
 
However, comparing characteristics of organization of care on a hospital level may 
have introduced misclassification bias. Whereas there was no individual information on 
co-care of mother-infant or use of NIDCAP, infants admitted to home care could be 
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identified in the PNQ-register. An option for organized home care was reported by 11 
of 21 hospitals. However, only 110 infants were actually discharged to home care and 
PMA at discharge for these infants was on average 9.8 days lower as compared to 
infants discharged home without organised support (p<0.001). By adding NU 
characteristics available on an individual level into the multivariate regression model 
with maternal and neonatal risk factors, the r2–factor for PMA at discharge increased 
from 13% to 21%. 
 
Breastfeeding and PMA at discharge 
Exclusive breastfeeding at discharge was seen in 56% of the infants and 22% were 
partly breastfed (missing data for 199 infants). Infants that were (exclusively or in part 
breastfed) had on average 2,7 days lower PMA at hospital discharge as compared to 
infants that were not breastfed (p<0.001). When controlling for maternal risk factors 
and neonatal morbidity in multivariate analysis, the difference in PMA at discharge 
between breastfed and not breastfed infants decreased to 1.9 days.  
 
 
5.3 NEONATAL MORBIDITY 
A comparison of neonatal morbidity between the different study populations is shown 
in Table 9. Overall, the rates of morbidity and interventions were robust. RDS was 
more common in Paper I, possibly due to misclassification (there is no data on TTN to 
compare with the more recent cohorts). Treatment with nCPAP, ventilator and 
antibiotics was slightly less common in Paper II, probably reflecting the exclusion of 
the most complicated cases. 
 
Table 9. Neonatal morbidity among moderately preterm infants in Paper I-IV 
 Paper I Paper II Paper III Paper IV 
Birth years 1983, 1988, 
1993, 1998, 
2002 
2004-2005 2004-2008 2004-2008 
Setting Danderyd 
Hospital 
National data National data National data 
Subgroup Exclusion of: 
malformations, 
major surgery, 
neonatal death  
Exclusion of: 
malformations, 
major surgery, 
neonatal death  
All live births 
included 
 
 
All live born 
singletons 
included 
 
N of included infants 564 2,388 6,674 4,679 
Antenatal steroids No data 37% 38% 36% 
TTN No data 14% 14% 17% 
RDS 17% 12% 14% 13% 
Infection No data 13%  15% 15% 
Hypoglycemia No data 18% 16% 20% 
Hyperbilirubinemia No data 59% 59% 61% 
BPD 0.5% 0.9% 1% 0.6% 
nCPAP therapy 42% 38% 43% 43% 
Ventilator therapy 6.9% 3.3% 5.5% 5.9% 
Antibiotic treatment 32%  28% 30% 31% 
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Respiratory morbidity in moderately preterm in relation to late preterm-term 
infants (Paper IV) 
Rates of neonatal respiratory morbidity in moderately preterm infants compared to late 
preterm to term infants are presented in Table 10. Overall, the most common 
respiratory diseases were TTN, followed by RDS. Compared with late preterm to term 
infants, very to moderately preterm infants had substantially increased risks of all 
respiratory diseases. Specifically, the risks of TTN and RDS were 23 and 180 times 
higher in very to moderately preterm infants compared to the reference population.   
 
Table 10. Risk of respiratory morbidity in moderately preterm infants as compared to late 
preterm to term newborn infants (singletons only). 
  
Late Preterm to 
Term Infants 
(35-41 weeks) 
n = 467,629 
 
Moderately Preterm 
Infants 
(30-34 weeks) 
n = 4,679 
 
 
 n % N % OR 95% CI 
Transient Tachypnea of the 
Newborn 
3,899 0.83 781 16.7 23 30-35 
Respiratory Distress 
Syndrome 
376 0.08 593 12.7 180 158-206 
Pneumothorax/PIE 657 0.14 116 2.48 18 15-22 
Pneumonia 629 0.13 45 0.96 7.2 5.3-9.8 
Persistent Pulmonary 
Hypertension 
210 0.04 43 0.92 21 15-29 
Meconium Aspiration 
Syndrome 
297 0.06 5 0.11 1.7 0.7-4.1 
Bronchopulmonary 
Dysplasiaa 
37 0.01 30 0.64 82 50-132 
OR = Odds Ratio; CI =  Confidence interval; PIE = Pulmonary Interstitial Emphysema 
aneed of oxygen at 36 weeks gestational age 
 
5.3.1 Neonatal morbidity by gestational week (Paper III) 
Rates and risks of morbidity at each gestational week are presented in Table 11. With 
the exception of hypoglycemia, all morbidity outcomes had a significantly decreasing 
trend towards higher GA (p <0.05). Compared to infants born at 34 weeks, infants born 
at 30 weeks had a twelve-fold increased risk of RDS, a four-fold increased risk of 
infections and a more than three-fold risk of hyperbilirubinemia. Major neonatal 
morbidity - defined as IVH, PVL, NEC, BPD and/or ROP – was reported to be rare (< 
0.5%) at 33-34 weeks of GA. Compared to infants born at 32 weeks, infants born at 30 
weeks had a two-fold increased risk of any IVH, a six-fold increased risk of NEC and 
an eight-fold increased risk of any ROP or BPD. In contrast, GA did not influence risks 
for IVH grade 3-4, PVL and ROP ≥ grade 3. Death before discharge to home occurred 
in 76 (1.1%) infants (15 [2.4%] at 30 weeks, 9 [1.1%] at 31 weeks, 18 [1.7%] at 32 
weeks, 20 [1.2%] at 33 weeks and 14 [0.5%] at 34 weeks). Forty-eight of the 76 infants 
died during the first 6 completed days of life and 14 died within 7 to 27 completed days 
of life. 
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Table 11. N
eonatal m
orbidities in 6,674 infants born m
oderately preterm
  
 
30 w
eeks
n=623 
31 w
eeks
n=822 
32 w
eeks
n=1045 
33 w
eeks
n=1564 
34 w
eeks
n=2620 
Total
n=6674 
 
%
 
O
R
 (95%
 C
I) 
%
 
O
R
 (95%
 C
I) 
%
 
O
R
 (95%
 C
I) 
%
 
O
R
 (95%
 C
I) 
%
 
O
R
 (95%
 C
I) 
%
 
Transient tachypnea of the new
born 
19 
2.1 (1.7-2.7) 
19 
2.0 (1.7-2.5) 
18 
2.0 (1.6-2.5) 
13 
1.3 (1.1-1.6) 
10 
1.0 (ref)
14 
R
espiratory distress syndrom
e 
40 
12.2 (9.6-15) 
26 
6.5 (5.1-8.2) 
16 
3.6 (2.8-4.6) 
9 
1.8 (1.4-2.3) 
5.1 
1.0 (ref)
14 
H
ypoglycem
ia* 
12 
0.7 (0.5-0.9) 
14 
0.8 (0.7-1.0) 
14 
0.9 (0.7-1.0) 
17 
1.0 (0.9-1.2) 
17 
1.0 (ref)
16 
Infection 
31 
4.3 (3.5-5.4) 
21 
2.6 (2.0-3.2) 
17 
2.0 (1.6-2.5) 
13 
1.5 (1.2-1.8) 
9.3 
1.0 (ref)
15 
Patent ductus arteriosus 
8.8 
23.0 (12-44) 
4.3 
10.5 (5.3-21) 
1.8 
4.4 (2.1-9.3) 
0.6 
1.5 (0.6-3.6) 
0.4 
1.0 (ref)
1.9 
H
yperbilirubinem
ia 
76 
3.4 (2.8-4.1) 
72 
2.7 (2.3-3.2) 
66 
2.1 (1.8-2.4) 
60 
1.6 (1.4-1.8) 
48 
1.0 (ref)
59 
Intraventricular haem
orrhage 
   - any                        
   - severe† 
 
8.3 
1.6 
 
2.4 (1.6-3.8) 
1.5 (0.6-3.6) 
 
6.2  
1.1 
 
1.8 (1.2-2.8) 
1.0 (0.4-2.5) 
 
3.5 
1.1 
1.0 (ref) 
1.0 (ref) 
 
0.2 
0 
 - - 
 
<0.1 
<0.1 
 - - 
 
2.1 
0.5 
Periventricular leukom
alacia 
1.6 
1.5 (0.6-3.6) 
1.1 
1.0 (0.4-2.5) 
1.0 
1.0 (ref) 
0.3 
- 
0.1 
- 
0.5 
N
ecrotizing enterocolitis 
1.9 
5.7 (2.4-14) 
0.5 
1.4 (0.4-4.6) 
0.8 
2.2 (0.9-5.8) 
0.6 
1.7 (0.7-4.2) 
0.3 
1.0 (ref) 
0.6 
R
etinopathy of prem
aturity 
   - any 
   - severe‡ 
 
2.4 
<0.1 
 
8.6 (2.5-30) 
0.8 (0.1-9.2) 
 
1.1 
<0.1 
 
3.8 (1.0-14) 
0.6 (0.1-7.0) 
 
0.3 
<0.1 
1.0 (ref) 
1.0 (ref) 
 0 0 
 - - 
 0 0 
 - - 
 
0.4 
<0.1 
Bronchopulm
onary dysplasia§ 
3.9 
8.7 (4.3-18) 
2.2 
4.9 (2.3-10) 
1.0 
2.1 (0.9-4.9) 
0.4 
0.8 (0.3-2.2) 
0.5 
1.0 (ref) 
1 
D
eath before discharge 
2.4 
4.6 (2.2-9.6) 
1.1 
2.1 (0.9-4.8) 
1.7 
3.3 (1.6-6.6) 
1.2 
2.4 (1.2-4.8) 
0.5 
1.0 (ref) 
1.1 
N
um
bers are proportions of patients (percent); O
R
 odds ratios; C
I confidence intervals. 
* H
ypoglycem
ia w
as defined as plasm
a glucose level <2.6 at an age of ≥3 hours. 
† Severe intraventricular hem
orrhage w
as defined as grade 3-4 
‡ Severe retinopathy of prem
aturity w
as defined as grade 3-5 
§ BPD
 w
as defined as need for oxygen supplem
entation at 36 w
eeks of gestational age. 
     Table 12. Interventions and treatm
ents by gestational w
eek in 6,674 infants born m
oderately preterm
 
 
30 w
eeks
n=623 
31 w
eeks
n=822 
32 w
eeks 
n=1,045 
33 w
eeks
n=1,564 
34 w
eeks
n=2,620 
Total
n=6,674 
 
%
 
O
R
 (95%
 C
I) 
%
 
O
R
 (95%
 C
I) 
%
 
O
R
 (95%
 C
I) 
%
 
O
R
 (95%
 C
I) 
%
 
O
R
 (95%
 C
I) 
%
 
Antenatal steroids 
70 
1.6 1.3-2.0) 
68 
1.5 (1.3-1.8) 
58 
1.0 (ref) 
39 
0.4 (0.4-0.5) 
12 
0.1 (0.1-0.1) 
38 
nC
PAP 
80 
10.5 (8.5-13) 
68 
5.8 (4.9-6.9) 
53 
3.2 (2.7-3.7) 
38 
1.7 (1.5-2.0) 
27 
1.0
(ref)
43 
Ventilator 
16 
7.6 (5.5-11) 
10 
4.4 (3.2-6.2) 
6.3 
2.7 (1.9-3.8) 
3.6 
1.5 (1.0-2.2) 
2.4 
1.0
(ref)
5.5 
Surfactant 
17 
12.9 (8.9-19) 
11 
7.8 (5.4-11) 
5 
3.3 (2.2-5.0) 
3.8 
2.5 (1.7-3.8) 
1.6 
1.0
(ref)
5.2 
Antibiotics 
64 
8.3 6.8-10) 
47 
4.1 (3.4-4.8) 
36 
2.7 (2.3-3.1) 
26 
1.6 (1.4-1.9) 
18 
1.0
(ref)
30 
Pharm
acological closure of patent ductus arteriosus 
4.3 
40 (12-130) 
2.0 
17.3 (5-60) 
1.1 
10.1 (2.9-36) 
0.3 
2.2 (0.5-10) 
0.1 
1.0
(ref)
0.9 
Surgical ligation  of patent ductus arteriosus 
0.6 
4.2 (1.1-17) 
0.2 
1.6 (0.3-8.7) 
0.2 
1.3 (0.2-6.9) 
0.1 
0.8 (0.2-4.6) 
0.2 
1.0
(ref)
0.2 
Exchange transfusion for hyperbilirubinem
ia 
0.2 
0.3 (0-2.0) 
0.5 
0.8 (0.3-2.4) 
1.0 
1.7 (0.8-3.7) 
0.4 
0.6 (0.2-1.6) 
0.6 
1.0
(ref)
0.6 
N
um
bers are proportions of patients (percent); O
R
 odds ratios; C
I confidence intervals. 
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Malformations 
Two hundred infants (3.0%) had one or more malformations (including malformations 
of the central nervous system n=11, eye/ear/neck/face n=10, cardiovascular n=96, 
airway including cleft palate n=26, gastrointestinal n=56, external genitals n=30, 
renal/urinary tract n=28, musculoskeletal n=52, and miscellaneous n=7) and/or 
chromosomal aberrations (n=33 [0.5%], including trisomy 21 [n=16], trisomy 18 [n=1], 
trisomy 13 [n=8] and Klinefelter syndrome [n=2]). Infants with malformation 
diagnoses or chromosomal aberrations had a higher mortality (n=23, 12%) than other 
infants (n=53, 0.8%).  
 
Treatments and interventions 
Treatment and intervention outcomes according to GA are presented in Table 12. With 
the exception of exchange transfusion, all interventions were more commonly used 
towards lower gestational ages (p <0.05 when tested by a non-parametric test for trend).  
 
5.3.2 Risk factors for neonatal morbidity (Paper III + IV) 
Intrauterine growth and morbidity (Paper III) 
SGA (birth weight for gestational age more than 2 SD below the mean for normal fetal 
growth) was seen in 8% of infants born at 34 and in 23% of infants born at 30 weeks 
(test for trend: p < 0.05) in Paper III. Compared to infants with birth weight for 
gestational age between -1 and +1 SD, SGA infants had an almost doubled risk of 
infection, a doubled risk of PDA and IVH, a three-fold increased risk of NEC or ROP 
and a five-fold increased risk of BPD (Table 13). Risks for these diagnoses were not 
significantly increased in other birth weight for gestational age groups. Compared to 
infants with birth weights for gestational age between -1 and +1 SD, SGA infants (<-2 
SD) had a five-fold and infants with birth weights >+2SD had a four-fold increased risk 
of BPD. Respiratory distress syndrome, severe IVH and PVL did not correlate to birth 
weight standard deviations. 
 
Table 13. Neonatal morbidity in moderately preterm infants by birth weight for gestational age. 
 <-2SD 
n=840 
-2 to <-1SD 
n=1,501 
-1 to +1SD 
n=3,700 
>+1 to ≤+2SD 
n=456 
>+2SD 
n=177 
Test for trend 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) p-value 
RDS  1.2 (0.9-1.4) 1.0 (0.8-1.2) 1.0 1.0 (0.7-1.3) 0.6 (0.4-1.1) 0.092 
Infection 1.6 (1.3-1.9) 1.1 (0.95-1.34) 1.0 0.9 (0.7-1.2) 1.5 (1.0-2.2) 0.001 
PDA  2.1 (1.4-3.3) 1.2 (0.8-1.9) 1.0 0.4 (0.1-1.2) 0.3 (0.0-2.3) <0.001 
IVH 
   any 
   severe* 
 
2.5 (1.7-3.8) 
1.8 (0.7-4.5) 
 
1.2 (0.8-1.8) 
1.0 (0.4-2.5) 
 
1.0 
1.0 
 
1.0 (0.5-2.1) 
1.6 (0.5-5.6) 
 
1.3 (0.5-3.6) 
1.4 (0.2-11) 
 
0.001 
0.685 
PVL  1.5 (0.6-3.7) 1.0 (0.4-2.3) 1.0 1.4 (0.4-4.6) 3.5 (1.0-12) 0.556 
NEC  2.9 (1.4-5.8) 0.9 (0.4-2.0) 1.0 1.0 (1.0-1.0) 2.1 (0.5-9.0) 0.013 
ROP  
  any 
  severe† 
 
3.2 (1.3-8.0) 
- 
 
1.6 (0.6-4.0) 
- 
 
1.0 
1.0 
 
1.0 (1.0-1.0) 
- 
 
1.9 (0.2-15) 
- 
 
0.013 
0.052 
BPD‡ 4.9 (2.7-8.8) 1.7 (0.9-3.3) 1.0 1.9 (0.7-4.9) 3.9 (1.3-11) 0.001 
Intrauterine growth characterized by standard deviation (SD) from expected birth weight. Numbers are 
proportions of patients (percent) and p-values. Test for trend across standard deviation groups is non-
parametric. RDS = Respiratory Distress Syndrome; PDA = Patent Ductus Arteriosus; IVH = 
Intraventricular Haemorrhage; PVL = Periventricular Leukomalacia; NEC = Necrotizing Enterocolitis; ROP 
= Retinopathy of Prematurity; BPD = Bronchopulmonary Dysplasia 
* Severe intraventricular hemorrhage was defined as grade 3-4 
† Severe retinopathy of prematurity was defined as grade 3-5 
‡ Bronchopulmonary dysplasia was defined as need for oxygen therapy at 36 weeks of gestational age 
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Maternal risk factors for TTN (Paper IV) 
Among very to moderately preterm infants, maternal age >35 years, multiparity, 
preeclampsia and all forms of Cesarean deliveries increased risk of TTN in the 
univariate analysis and premature rupture of membranes decreased the risk. In the 
adjusted analysis, multiparity increased the risk of TTN by 30%, Cesarean section after 
onset of labor increased the risk with 30% and Cesarean section before onset of labor 
increased the risk by 60%. Maternal BMI between 25.0-29.9 decreased the risk of TTN.  
 
Maternal risk factors for RDS (Paper IV) 
In univariate analyses, multiparity; BMI >30; chronic disease; preeclampsia; Cesarean 
section before; and after onset of labor were associated with increased risks for RDS 
and premature rupture of membranes was associated with a decreased risk of RDS. In 
the adjusted analysis, Cesarean section after onset of labor doubled the risk of RDS, 
Cesarean section before onset of labor more than doubled the risk and premature 
rupture of membranes decreased the risk of RDS by 50 % (Table 14). 
 
Table 14. Maternal, pregnancy and delivery-related risk factors for Transient Tachypnea of the Newborn 
and Respiratory Distress Syndrome among moderately preterm infants. 
 Transient tachypnea of the newborn 
(n = 663) 
 Respiratory distress syndrome 
(n = 630) 
 Odds Ratios (95% CI)  Odds Ratios (95% CI) 
 Crude Adjusted  Crude  Adjusted 
Maternal age 
<24 
25-29 
30-34 
≥35 
 
1.00 (ref)  
0.85 (0.64-1.12) 
1.21 (0.93-1.57) 
1.36 (1.04-1.79) 
 
1.00 (ref) 
0.82 (0.60-1.12) 
1.09 (0.81-1.47) 
1.02 (0.74-1.41) 
  
1.00 (ref) 
1.01 (0.76-1.33) 
1.11 (0.85-1.47) 
1.25 (0.94-1.65) 
 
1.00 (ref) 
0.99 (0.71-1.37) 
0.91 (0.65-1.26) 
0.84 (0.60-1.20) 
Parity 
Primiparous 
Multiparous 
 
1.00 (ref) 
1.38 (1.17-1.63) 
 
1.00 (ref) 
1.28 (1.05-1.56) 
  
1.00 (ref) 
1.41 (1.19-1.67) 
 
1.00 (ref) 
1.46 (1.18-1.81) 
BMI 
≤24.9 
25.0-29.9 
≥30.0 
 
1.00 (ref) 
0.86 (0.69-1.07) 
1.05 (0.81-1.38) 
 
1.00 (ref) 
0.79 (0.62-0.99) 
0.92 (0.69-1.21) 
  
1.00 (ref) 
1.00 (0.79-1.25) 
1.40 (1.09-1.81) 
 
1.00 (ref) 
0.95 (0.75-1.22) 
1.10 (0.82-1.46) 
Daily smoking in early 
pregnancy 
No 
Yes 
 
1.00 (ref) 
1.12 (0.84-1.49) 
 
1.00 (ref) 
1.15 (0.85-1.56) 
  
1.00 (ref) 
1.05 (0.78-1.42) 
 
1.00 (ref) 
0.82 (0.59-1.16) 
Chronic disease 
No 
Yes 
 
1.00 (ref) 
1.06 (0.83-1.37) 
 
1.00 (ref) 
1.05 (0.80-1.38) 
  
1.00 (ref) 
1.37 (1.08-1.75) 
 
1.00 (ref) 
1.31 (1.00-1.73) 
Assisted conception 
No  
Yes 
 
1.00 (ref) 
1.12 (0.79-1.59) 
 
1.00 (ref) 
1.24 (0.86-1.79) 
  
1.00 (ref) 
0.84 (0.57-1.24) 
 
1.00 (ref) 
0.81 (0.52-1.25) 
Preeclampsia 
No  
Yes 
 
1.00 (ref) 
1.33 (1.08-1.63) 
 
1.00 (ref) 
0.99 (0.76-1.28) 
  
1.00 (ref) 
1.63 (1.33-1.99) 
 
1.00 (ref) 
0.84 (0.64-1.09) 
PPROM 
No  
Yes 
 
1.00 (ref) 
0.76 (0.63-0.92) 
 
1.00 (ref) 
0.81 (0.65-1.02) 
  
1.00 (ref) 
0.42 (0.34-0.52) 
 
1.00 (ref) 
0.50 (0.38-0.66) 
Mode of delivery 
Vaginal delivery 
CS after onset of labor 
CS before labor 
Unspecified CS 
 
1.00 (ref) 
1.50 (1.25-1.79) 
2.00 (1.47-2.73) 
1.70 (1.14-2.54) 
 
1.00 (ref) 
1.27 (1.02-1.58) 
1.59 (1.10-2.30) 
1.50 (0.96-2.33) 
  
1.00 (ref) 
2.74 (2.27-3.31) 
3.40 (2.49-4.65) 
1.59 (0.99-2.54) 
 
1.00 (ref) 
2.13 (1.67-2.72) 
2.57 (1.75-3.77) 
1.26 (0.74-2.15) 
The multivariate model is adjusted for maternal age, parity, BMI, daily smoking in early pregnancy, chronic 
disease, assisted conception, preeclampsia, premature rupture of membranes, mode of delivery and 
infant’s gestational age. 
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Infant related risk factors for TTN (Paper IV) 
In univariate analyses, antenatal steroids; male sex; Apgar score 4-6 at 5 minutes; and 
gestational age 30-33 weeks were associated with increased risks for TTN among very 
to moderately preterm infants. After adjustment for gestational age only, antenatal 
corticosteroids was no longer associated with an increased risk of TTN. Male sex 
increased the risk of TTN by 30 % and Apgar score 4-6 increased the risk by 75 %. 
Adding infant characteristics (antenatal corticosteroid therapy; SGA status; sex; and 
Apgar score at 5 minutes’ age) to the adjusted model with gestational age, did not 
change the risk estimates significantly. 
 
Infant related risk factors for RDS (Paper IV) 
Among very to moderately preterm infants, antenatal steroids; male sex; Apgar score 0-
3 and 4-6; and gestational age 30-33 weeks (compared to 34 weeks) were associated 
with increased risks for RDS in univariate analyses. After adjustment for gestational 
age only, antenatal steroid therapy and SGA decreased the risk of RDS by 30 %, 
whereas an Apgar score between 0-3 almost tripled the risk and an Apgar score 
between 4 and 6 almost doubled the risk of RDS. Male sex still increased the risk by 30 
%. As with risks for TTN, adding antenatal corticosteroid therapy; SGA status; sex; and 
Apgar score at 5 minutes’ age to the multivariate model on risk of RDS, did not change 
risk estimates significantly but the difference in risks between gestational age weeks 
increased (data not shown, Table 15). Tests for interaction between SGA and GA on 
the risk of RDS were performed but no effect modification was detected. 
 
Table 15. Infant related risk factors for Transient Tachypnea of the Newborn and Respiratory 
Distress Syndrome among moderately preterm infants.  
 Transient tachypnea of the newborn 
(n = 663) 
Respiratory distress syndrome 
(n = 630) 
  
OR (95% CI) 
 
OR (95% CI) 
  
Crude 
 
Adjusted 
model 1 
 
Adjusted 
model 2 
 
Crude 
 
Adjusted 
model 1 
 
Adjusted 
model 2 
Antenatal corticosteroid 
therapy 
No  
Yes 
 
 
1.0 (ref) 
1.4 (1.2-1.6) 
 
 
1.0 (ref) 
1.0 (0.8-1.2) 
 
 
1.0 (ref) 
1.0 (0.8-1.2) 
 
 
1.0 (ref) 
1.5 (1.3-1.8) 
 
 
1.0 (ref) 
0.7 (0.6-0.9) 
 
 
1.0 (ref) 
0.8 (0.6-0.9) 
SGA status 
No  
Yes 
 
1.0 (ref) 
1.1 (0.8-1.4) 
 
1.0 (ref) 
0.9 (0.7-1.2) 
 
1.0 (ref) 
0.9 (0.7-1.2) 
 
1.0 (ref) 
1.1 (0.8-1.4) 
 
1.0 (ref) 
0.7 (0.5-0.9) 
 
1.0 (ref) 
0.7 (0.6-1.0) 
Sex 
Female  
Male 
 
1.0 (ref) 
1.3 (1.1-1.5) 
 
1.0 (ref) 
1.3 (1.1-1.5) 
 
1.0 (ref) 
1.3 (1.1-1.6) 
 
1.0 (ref) 
1.4 (1.2-1.7) 
 
1.0 (ref) 
1.4 (1.2-1.7) 
 
1.0 (ref) 
1.4 (1.2-1.7) 
Apgar score 5 min 
0-3 
4-6 
7-10 
 
1.3 (0.6-2.7) 
1.7 (1.2-2.4) 
1.0 (ref) 
 
1.2 (0.6-2.4) 
1.6 (1.1-2.2) 
1.0 (ref) 
 
1.1 (0.5-2.4) 
1.6 (1.1-2.2) 
1.0 (ref) 
 
3.4 (1.9-6.1) 
2.3 (1.6-3.1) 
1.0 (ref) 
 
2.8 (1.5-5.3) 
1.9 (1.3-2.6) 
1.0 (ref) 
 
3.1 (1.6-5.9) 
1.8 (1.3-2.6) 
1.0 (ref) 
Gestational age 
30 weeks 
31 weeks 
32 weeks 
33 weeks 
34 weeks 
 
2.2 (1.7-3.0) 
2.0 (1.6-2.6) 
1.8 (1.4-2.3) 
1.2 (1.0-1.6) 
1.0 (ref) 
  
2.3 (1.7-3.1) 
2.0 (1.5-2.7) 
1.9 (1.4-2.4) 
1.2 (0.9-1.5) 
1.0 (ref) 
 
9.4 (7.1-12.4) 
5.4 (4.1-7.0) 
3.0 (2.3-3.9) 
1.5 (1.2-2.0) 
1.0 (ref) 
  
11.3 (8.2-15.5) 
6.5 (4.9-8.8) 
3.4 (2.6-4.6) 
1.6 (1.2-2.2) 
1.0 (ref) 
Model 1 adjusts for gestational age. 
Model 2 adjusts for antenatal corticosteroid therapy, SGA status, sex, Apgar score at 5 minutes’ age and 
gestational age. 
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6 GENERAL DISCUSSION 
6.1 LENGTH OF HOSPITAL STAY 
In our longitudinal study of length of hospital stay in moderately preterm infants in a 
one-hospital setting, the main finding was that length of stay was significantly shorter 
in 2002 compared to previous year cohorts. The difference in length of stay (or 
postmenstrual age at discharge) between 1983 and 2002 was 9 days. This could not be 
attributed to healthier infants in 2002. In a population-based study of 2,388 moderately 
preterm infants born 2004-2005, we found that postmenstrual age at discharge differed 
up to two weeks between hospitals and that perinatal risk factors and neonatal 
morbidity only had a limited impact on length of hospital stay for these infants.  
 
Previous studies have suggested that length of stay for preterm infants is much less 
influenced by morbidity and neonatal risk factors than expected.96,97 There is general 
consensus that all preterm infants should have achieved physiological stability before 
they are sent home. But there are no accepted definitions of temperature and respiratory 
stability in Sweden. Accordingly, there may be variations in the margins of safety; 
including the time elapsed after documented physiologic temperature and respiratory 
stability, before discharge.98,99   
 
Hospitalisation is stressful for both infants and parents. The ambition should always be 
to restrain the LOS as much as safety allows.18 Early hospital discharge has been 
reported to increase the risk of readmission for late preterm infants.100 Costs for 
neonatal care are closely related to length of stay.77,89,101,102 In Sweden, 2% of all live-
born infants are moderately preterm, but they account for almost 50% of total bed-days 
in the NU (Paper I). Shortening length of stay for moderately preterm infants by nine 
days – the effect associated with organized home care in previous studies25 – would 
reduce the total need for neonatal beds by 15%. This permits reallocation of NU 
resources to the growing number of infants surviving extremely preterm birth. 
 
In Paper I, morbidity in terms of asphyxia, RDS and BPD did not change over time. 
Use of nCPAP treatment increased in later years, probably replacing some of the need 
for ventilator treatment. It is conceivable that the introduction of surfactant therapy 
during the latter half of the study period may have contributed to shorter LOS. 
However, rates of RDS was on average fairly low (17%) and it did not change over 
time. In addition, the course of RDS was usually mild to moderate. Accordingly, 
surfactant therapy was uncommon and could only have had a marginal, if any, effect on 
length of stay in these moderately preterm infants. Treatment with antenatal steroids in 
preterm labor was introduced in 1985 at our hospital and could therefore not explain the 
later drop in length of hospital stay. 
  
It is well known that a low birth weight for gestational age predicts a higher risk of 
morbidity and mortality.103 This was reflected also in Paper I, which found longer 
LOS for SGA infants. Likewise, the longer LOS found among infants treated with 
nCPAP reflects their underlying respiratory or circulatory fragility.  
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Breastfeeding has important short and long term health implications for preterm 
infants.104,105 Establishment of successful breastfeeding in preterm infants should 
therefore be given high priority in neonatal care.106 In contrast to previous 
reports,95,107,108 we found that breastfed infants in Paper II had a lower PMA at 
discharge as compared to those not breastfed. After controlling for neonatal morbidity, 
the difference between the two groups decreased. This suggests that the lower PMA at 
discharge in breastfed infants may partly be due to that breastfed infants are healthier 
and more mature as compared to not breastfed infants. In addition, a majority of the 
preterm infants were exclusively breastfed before discharge, thereby allowing for 
discharge at home as soon as physiologic stability had been achieved.  
 
Apnea of prematurity has been reported to significantly increase LOS in moderately 
preterm infants and that diagnosis of apnea varies considerably between hospitals.99 
The register from which we extracted data did not contain information on the 
proportion of infants with apnea of prematurity, which precludes an analysis of the 
effects of this diagnosis on PMA at discharge. Even though it is clear that morbidity is 
not the main determinant of LOS, we cannot exclude that neonatal morbidity below 32 
weeks of GA may be more important for LOS than presently reported. A more detailed 
analysis of morbidity data in each GA strata and its relation to LOS is a topic for further 
research.  
 
6.2 ORGANIZATIONAL ASPECTS ON NEONATAL CARE 
From the findings that LOS was shortened during the last 20 years without a 
corresponding decrease in neonatal morbidity, we hypothesized that changes in 
organization of care for moderately preterm infants may have had some impact on the 
decrease in length of stay. In Paper II, organization of care seems to be equally or 
even more important than perinatal risk factors for length of hospital stay. 
 
Increasing admission rates and overcrowding in the NU may have contributed to the 
development of shorter hospital stay in Paper I. But there was also a growing parental 
demand for earlier discharge and a proactive search for new and safe strategies to 
avoid unnecessary hospitalisation of infants and parents. Two major changes in 
nursing care were made during the study period that may have been of importance for 
the decrease in length of stay: the introduction of organized home care in 1998 and 
the incorporation of routine use of NIDCAP into nursing care.  
 
Organized home care can be a strategy to discharge infants earlier with maintained 
safety and to counteract readmissions. Early discharge has been associated with lower 
risk of nosocomial infection,25 a better parental preparedness and a tendency to 
perceive the infants as being healthier.26  Moreover, early discharge to home care has 
not been reported to increase readmissions.25 Designed to decrease stress for the 
preterm infant, NIDCAP customizes care to match individual needs, involves parents 
more in the care of their infant and may save costs and resources.109  
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At Danderyd Hospital, Stockholm (Paper I), transfer of infants to other secondary level 
neonatal units before discharge to home became somewhat more common in 2002 than 
the years before due to a rising number of births without a corresponding increase of 
NU beds. This was a contributing factor to the overall decrease in length of stay during 
2002. However, shorter hospital stay because of patient transfer does not decrease costs 
for the society because the care continues in another unit. In addition, parents often 
experience increased stress and anxiety in these situations and transfer of infants 
between units and hospitals should be limited to those instances in which there is a 
medical indication. 
 
In Paper I, length of neonatal stay for moderately preterm infants decreased in average 
14 days from 1983 to 2002. Assuming that 2200 moderately preterm infants are born in 
Sweden every year and that the average length of stay is reduced by 14 days, national 
savings would be worth an estimated 330 million SEK (52,8 million USD)/year. In 
Paper II, mean postmenstrual age at discharge differed almost two weeks between the 
most extreme clinics. With the assumption that these hospitals had 50 admitted 
moderately preterm infants every year, and that costs for neonatal care is the same as in 
Karolinska Hospital, the clinic with the highest LOS would have costs that are 7.5 
million SEK (1.2 million USD) higher than the clinic with the shortest LOS every year. 
It should be noted that this difference is calculated only in the moderately preterm 
group. Although these examples are crude, the savings and/or costs for society that can 
be calculated this way are nonetheless worth a thought. 
 
In Sweden and in other countries, centralization of neonatal care to improve outcome is 
only recommended for extremely preterm infants. As demonstrated in Paper III, 
significant morbidity – qualifying many infants for neonatal intensive care – also 
occurs in very preterm infants. Reassuringly, infant mortality has not been found to 
differ between regional centers of excellence and general hospitals in infants born at 
28-31 weeks gestational age in Sweden.15 However, based on our findings, the 
discussion of how to organize neonatal care should perhaps not be restricted to the most 
immature group but also include very preterm infants. 
 
6.3 NEONATAL MORBIDITY 
The major finding in our national population-based study of 6,674 infants was that 
moderately preterm infants still have substantially increased risks for neonatal 
morbidity, despite general advances in perinatal care. Rates of neonatal morbidity for 
each gestational week were similar to results of previous reports.67,72,75,77 The 
morbidities increased as GA decreased from 34 to 30 weeks. In Paper IV, risks of TTN 
and RDS among moderately preterm infants were increased by 23 and 180 times, 
respectively, when compared with late preterm to term infants (born at 35-41 weeks). 
Nasal CPAP was the major treatment for respiratory problems, which differed 
markedly from other studies.67,77 
 
In a US study of infants born at 30-34 completed weeks, Escobar et al. found lower 
rates of IVH and ROP as compared to our study.67 In the US study, bronchopulmonary 
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dysplasia (defined similarly in both studies) was three times more common and infants 
were more often treated with ventilator than with nCPAP as compared to Sweden. In 
addition, 5 times more infants in the US study received surfactant compared to Sweden. 
These differences in acute management of respiratory disorders most likely reflect 
different care traditions.110 Nasal CPAP is frequently used in Sweden, not only for 
acute respiratory disorders but also to stabilize and decrease work of breathing and for 
treatment of apnea of prematurity. Such practice is poorly evidence-based in 
moderately preterm infants, but spontaneously breathing extremely preterm infants 
have been shown to benefit from nCPAP as compared to being mechanically ventilated 
from start.111 Kirkby et al.77  reported rates of PDA, BPD and NEC that were higher 
and rates of PVL and severe IVH that were lower than in our data for the same GAs. 
Similar to Escobar’s study, ventilator treatment was much more common than in our 
study.  
 
In Paper III, the overall rate of hypoglycemia was 16%, which is similar or higher as 
compared to rates previously reported in late preterm infants (6.8-16%)72,75 but lower 
than that seen in extremely preterm infants (41%).112 In view of these figures and of the 
fetal growth distributions, the finding of a trend towards gradually increasing 
prevalence of hypoglycemia in more mature infants, is intriguing. In Sweden, all 
preterm infants, also those without any symptoms, are repeatedly screened for 
hypoglycemia, the first blood test being performed within 3 hours after birth. However, 
we cannot exclude that there are GA-related differences in screening procedures that 
could have contributed to the unexpected trend of increasing prevalence of 
hypoglycemia at higher GA. Prevention of hypoglycemia may also have been more 
effective at lower GA because of more frequent use of intravenous glucose infusions in 
infants with acute respiratory disorders. Finally, we had no data on the distribution of 
maternal diabetes – a known risk factor for neonatal hypoglycemia – in relation to GA. 
 
6.4 RISK FACTORS FOR ACUTE RESPIRATORY MORBIDITY 
The very to moderately preterm infants represent a large group at the neonatal unit that 
generally has a good prognosis. However, a substantial part of these infants experience 
medical problems and complications resulting from their prematurity. Among these 
problems, acute respiratory disorders stand out as a leading morbidity category.  
 
In our national population-based study, analyses of risk factors for the two most 
common respiratory disorders within the group of moderately preterm infants, TTN and 
RDS, revealed three important findings: first, increased risks for both TTN and RDS 
were associated with low GA, low Apgar scores and delivery by Cesarean section, as 
well as with multiparity and male sex. Second, vaginal delivery, premature rupture of 
membranes, antenatal corticosteroid therapy and SGA status were associated with a 
reduced risk of RDS. Finally, maternal age, obesity, assisted reproduction, smoking in 
pregnancy, chronic disease or preeclampsia did not affect the risk of acute respiratory 
morbidity in moderately preterm infants. 
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Cesarean section, both before and after onset of labor, more than doubled the risk of 
RDS. In addition, TTN was also more common after Cesarean section. This is in line 
with previous studies of term infants that have reported increased risks for neonatal 
respiratory morbidity after Cesarean section as compared to vaginal delivery, also after 
adjustment of other risk factors and confounders.113,114 There are several proposed 
explanations for the association between Cesarean section and neonatal respiratory 
disease. These include lack of mechanical squeezing of lung fluid during the passage 
through the birth canal, absence of molecular promotion of alveolar fluid drainage by 
activation of sodium channels,46 and lack of the physiological surge of stress 
hormones115 seen in the fetus during labor and vaginal delivery. 
 
Increasing Cesarean section rates116 could be one explanation for the increment in rates 
of both TTN and RDS found in moderately preterm infants. Since RDS is common 
with overall rates varying from 40% at 30 weeks of GA to 5% at 34 weeks of GA 
(Paper III), the added risk after Cesarean section carries a significant contribution to 
neonatal respiratory morbidity in absolute numbers.  
 
The finding that multiparity is associated to a higher risk of general respiratory 
morbidity has been reported by others.72,117 In our study, this association was restricted 
to TTN. Possible underlying mechanisms remain unclear, and other studies have found 
higher risks for general neonatal morbidity in nulliparous women.118 Few studies have 
focused on the association between parity and neonatal respiratory morbidity. 
 
The male disadvantage in neonatal respiratory morbidity is well known from previous 
studies. RDS and other respiratory diseases are more common in boys than in girls.119 
Preterm boys need more respiratory support than girls.120 The cause of this sex 
difference is so far largely unknown, but sex-specific hormonal influences on fetal lung 
development have been proposed.121  
 
PPROM has been associated with an increased risk118 or no risk122 for RDS in preterm 
infants. In contrast, our study showed that PPROM was protective of RDS. The risk of 
neonatal respiratory disease after PPROM is modified by many factors, such as GA, 
SGA status, latency period to delivery,118 presence of histological chorioamnionitis122 
and use of antibiotic therapy.48 Prenatal exposure to cytokines and inflammatory 
mediators during subclinical or clinical chorioamnionitis after prelabor premature 
rupture of membranes has been thought to accelerate fetal lung maturation and decrease 
the incidence of RDS,123 However, clinical observations have been contradictory and 
both beneficial and detrimental effects of inflammation on the fetal lung have been 
shown.124-126   
 
Although there is evidence that antenatal corticosteroid treatment is effective for RDS-
prevention in preterm infants,48,127 antenatal steroids were only administered to one 
third of the moderately preterm infants. This is most likely reflecting variations in 
practice with respect to the upper GA limit for steroid administration. We have 
previously found that 39% of Swedish pregnant women at 33 weeks and 12% at 34 
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gestational weeks were treated with antenatal corticosteroids (Paper III).  In a recent US 
study, infant mortality and respiratory distress syndrome rates were studied in preterm 
infants of 33-34 gestational weeks between 1995-97 and 2002-04. The conclusion was 
that treatment with antenatal steroids may be beneficial also in this group of moderately 
preterm infants.128 Given the high number of infants and a RDS-rate of 5-9 % (Paper 
III) at these gestational weeks, as well as the short and long-term safety of one-course 
antenatal corticosteroid treatment,48,50,127 current practice and recommendations in 
Sweden should be discussed. 
 
Intrauterine growth restriction (IUGR) has previously been regarded as a protective 
factor for RDS, according to similar lung maturation theories as with 
inflammation.129,130 Recently, the opinion seems to have changed towards a more 
cautious interpretation of the effect of IUGR on RDS. Studies have shown both 
increased and decreased RDS rates in SGA infants, and that the effect of IUGR may 
vary by gestational age.131 Animal models have shown that IUGR in fact does not 
accelerate lung maturation but delays it.132,133 In Paper III, SGA was significantly more 
common at lower GA and being born SGA was associated with increased risks for most 
of the observed neonatal diagnoses (but not RDS). 
 
6.5 INTERNAL AND EXTERNAL VALIDITY 
The two major threats to the validity of a scientific study are systematic and random 
errors. Random errors usually disappear with a larger sample size and are discussed 
further under “precision”. Systematic errors are also called bias, and will not decrease if 
the study sample is increased. Examples of common bias are selection bias, 
misclassification bias, recall bias and confounding. Selection bias occurs when 
participation in a study is associated to the incidence of exposure or outcome studied. 
Misclassification bias is occurring when data on the study subjects holds errors in a 
systematic way. Recall bias is when study subjects are asked questions in retrospect and 
the quality of collected data systematically differ between those with and without the 
disease. Confounding is when the association between a risk factor and an outcome is 
influenced by one or more other factors. There are many more examples of bias that 
will not be presented herein.134 In the study design, researchers must take all possible 
precautions to avoid bias. For example, measurements of risk factors and outcomes can 
be specified and standardized, study subjects blinded to the purpose of the study, data 
collectors blinded to the individual’s outcome, data collected prospectively and 
confounding factors identified and controlled for in statistical analyses.  
 
Internal validity 
If the result of a study can be trusted to be close to the true value in the studied 
population, the internal validity is said to be high. Bias, especially misclassification, 
recall bias and confounding, have a negative effect on internal validity.  
 
In this thesis, we have tried to improve the internal validity in several ways. In Paper I, 
the dating of pregnancies was made by last menstrual period in 1983-88 and by 
ultrasound scanning in most pregnancies in the later cohorts. To some degree, this 
could have confounded the comparisons of postmenstrual age at discharge between 
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early and later year cohorts. However, the decrease in postmenstrual age at discharge 
also appeared between 1993 and 2002, when ultrasound dating was generally used to 
estimate gestational age. The dating of pregnancies by last menstrual period resulted 
in an age estimate of completed gestational weeks. In the following cohorts, antenatal 
ultrasound was used for gestational age estimation and was expressed as completed 
weeks and days. To avoid underestimation of the postmenstrual age at discharge for 
the 1983 and 1988 cohorts, 3.5 days was added to the completed gestational weeks for 
those infants.  
 
The internal validity of studies II-IV depends mainly on the quality of the PNQ 
register. The prospective design and predefined diagnostic criteria for outcome 
measures minimizes the risk of recall bias. We have found very few missing data in 
Papers II-III. However, there has been no proper validation of the register. Another 
limitation is that infections could not be separated into subcategories and were 
presented in one group, including both life-threatening and relatively harmless 
infections. 
 
External validity 
When performing a study on a population sample, for example a group of patients 
with a specific diagnosis in a local hospital, the aim is always to extrapolate the 
results to a larger population, for example individuals with the same diagnosis all 
over the country, or even all over a continent. This is not always possible – 
populations are different, diagnostic tools vary across countries, clinical routines 
regarding diagnosis and treatment may differ between hospitals and even between 
doctors. The external validity is especially sensitive to selection bias.  
 
Paper I is based on data from a local Swedish hospital and it is perhaps not possible to 
generalize the results to a larger population. However, we suspect that similar results 
on length of hospital stay for moderately preterm infants can be found in at least the 
neonatal units in Stockholm County. Analogous results on admissions and utility of 
neonatal resources have also been found in the US.135   
 
As we cover a majority (63% in Paper II and 81% in Paper III-IV) of all Swedish 
moderately preterm infants born in recent years, the results of this thesis can be 
generalized to contemporary Scandinavian populations of infants born at 30-34 
gestational weeks. 
 
Precision 
Random errors are the variability in study results that cannot be explained by bias. The 
easiest way to deal with random errors is to increase the study sample. The minimum 
sample size must be estimated in advance before initiation of a study and is done by a 
power calculation. A properly performed statistical analysis is the next step to avoid 
random errors. 
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The number of included infants in the studies of this thesis was large, which provided 
high precision in estimates and a low risk of random errors. However, in Paper II, the 
number of included hospitals was too low to allow analyses on hospital level. 
 
6.6 CLINICAL IMPLICATIONS 
Moderately preterm births account for a large proportion of the growing population of 
preterm infants, as well as children and adults once born preterm. Contemporary reports 
on their neonatal period have been sparse in the recent decades but in the last years, we 
have observed an increased interest for these infants. Well-performed studies on their 
neonatal outcome and resource utilization may be helpful to renew medical knowledge 
and customize obstetric and neonatal care to the specific needs of moderately preterm 
infants.  
 
Our findings on length of hospital stay suggest that organization of neonatal care can be 
adapted to shorten hospital stay, for the benefit of infant, family and neonatal unit 
resources. The findings that neonatal morbidity has only a small impact on length of 
hospital stay and that postmenstrual age at discharge varies considerably between 
hospitals, can stimulate new evaluations of hospital stay in infants of all gestational 
ages, and local overviews to streamline organization of care. Organized home care and 
individualized care for newborn infants may decrease length of hospital stay with 
maintained safety level, and thereby allocate resources from healthy and relatively 
mature infants to more severely ill infants. In addition to well-known positive effects on 
health, nutrition and mother-infant relationship, our results indicate that breastfeeding is 
associated with a shorter length of hospital stay. 
 
As demonstrated in this thesis, moderately preterm infants are at high risk of neonatal 
morbidity. It seems that the general expectancy on outcome of moderately preterm birth 
is better than the actual numbers shown in this thesis. To highlight risks of neonatal 
morbidity, the results of the included studies may be used in specific education 
programmes. Based on our findings that infants in the lower gestational weeks of our 
study population are at such high risk of neonatal intensive care, centralization of care 
for infants born below 30-32 gestational weeks may be discussed in Sweden. 
 
Results on neonatal morbidity in this thesis may also add to knowledge and arguments 
in discussions between neonatologists and obstetricians when it comes to elective 
preterm delivery. This is most applicable in cases of relative maternal indication of 
moderately preterm delivery, such as pain, humanitarian causes or general discomfort. 
In these cases, a postponed delivery may be argued for on the basis of our results, 
which show that infants born at 30-34 gestational weeks by no means can be regarded 
as “almost term” or mature. This thesis also attempts to predict the infants most at risk 
of developing acute respiratory morbidity, which may increase clinical awareness of 
disease symptoms in exposed infants. In addition, the information provided can be used 
to individualize risk-assessment when counselling parents facing moderately preterm 
birth.  
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More specifically, the included morbidity studies in this thesis indicate that acute 
respiratory diseases are common in the moderately preterm group. The European 
guidelines recommend treatment with single-dose antenatal corticosteroids to all 
mothers giving birth before 35 completed gestational weeks. Given the rather high rate 
of RDS (5-9%) in infants of 33-34 gestational weeks in our studies, it seems reasonable 
to discuss an extension of antenatal steroid use to include these gestational ages in 
Sweden. 
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7 CONCLUSIONS 
 
• Length of stay at the neonatal unit has decreased significantly for moderately 
preterm infants over the last twenty years. We did not detect any changes in the 
panorama of diseases that could explain the shortening of length of stay. We 
conclude that individualized hospital care and development of home care have 
contributed to this finding. 
 
• Perinatal risk factors have small overall impact on length of hospital stay in 
moderately preterm infants. Organization of care is probably an important 
factor. The number of bed-days differs significantly between centres, which 
may have effects on quality of care and health economy. 
 
• Despite general advances in perinatal care, moderately preterm infants still 
face increased risks for neonatal morbidity and need for neonatal interventions 
and treatments. Morbidity rates increased as gestational age decreased, SGA 
was more common at lower gestational ages and being born SGA was 
associated with increased risks for most of the observed neonatal diagnoses. 
 
• Risks of TTN and RDS among moderately preterm infants (born at 30-34 
weeks) were increased by 23 and 180 times, respectively, when compared with 
late preterm to term infants (born at 35-41 weeks). Delivery by Cesarean 
section, low gestational age, low Apgar scores, and male sex were associated 
with higher risks for TTN and RDS. Antenatal corticosteroid therapy was 
associated with a reduced risk of RDS, and should be considered in all 
pregnancies with imminent preterm delivery at 34 weeks or less.  
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8 TOPICS FOR FUTURE RESEARCH 
Moderately preterm infants represent a large proportion of all preterm infants and at 
30-34 gestational weeks, they account for half the number of bed-days in NU and a 
third of all preterm infants. The research field of moderately preterm infants includes 
further areas to be mapped.  
 
The results on length of hospital stay in this thesis indicate that organized home care 
programs may be a method to reduce the hospital stay. This may have a positive impact 
on the cost-benefit of neonatal care in general. The modern health care system deals 
continuously with questions on how to use financial resources in the most effective 
way. Health economical evaluations on the transition from a full neonatal unit stay to 
discharge to home care after physiologic stabilization, would answer questions on this 
topic. 
 
Furthermore, results from our and other studies suggest that care organization is an 
important factor on length of hospital stay. These factors are often more difficult to 
evaluate than for examples measures of morbidity. How does staff numbers, workload, 
clinical and theoretical competence of staff, breastfeeding policies and care strategies 
affect length of stay? Some of these factors have been evaluated previously97,136,137 in a 
smaller context but no study takes them all into account. It would be of interest from a 
health economical point of view to evaluate which organizational changes can be made 
to reduce the length of hospital stay, with maintained quality of care, in this large group 
of infants at the neonatal unit. 
 
The relationship between IUGR and neonatal morbidity seems to be enigmatic. In our 
studies, SGA was a risk factor for most important neonatal diagnoses, but not all. In 
contrary, SGA reduced the risk of RDS in moderately preterm infants. Previous studies 
have shown both increased and decreased RDS incidence in SGA infants, and that the 
effect of IUGR may vary by gestational age.131 Further studies focusing on IUGR and 
risk of specified neonatal morbidity, stratified by gestational age and perhaps supported 
by genetic and animal studies, may help solve the puzzle. The susceptibility of some 
infants to adverse neonatal outcomes may not only be environmental, but also genetic. 
Studies on genetic association, generation studies and twin studies may help explain 
why some infants have complications from moderately preterm birth and others do not. 
 
As shown in this thesis, moderately preterm infants are at a substantial risk of 
morbidity and complications in the neonatal period. The next question is how they are 
doing as pre-school children, school children, adolescents and adults? There are a few 
studies published on long-term follow-up of moderately preterm infants, indicating that 
they face a higher risk of long-term disability,64,79  psychiatric disorder requiring 
hospitalization in adolescence,3, diabetes,2 hypertension,1 asthma82 and ADHD in 
childhood.83 Further studies on long-term consequences of moderately preterm birth in 
the modern era of neonatology are needed. 
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9 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Måttligt för tidig födsel, i den här avhandlingen definierad som födsel i 
graviditetsvecka 30-34, står för 2% av alla födslar per år i Sverige (~2 000 barn). Den 
övervägande majoriteten av de måttligt för tidigt födda barnen läggs in på 
neonatalavdelning för övervakning och tillmognad. Under senare år har man 
uppmärksammat bristen på vetenskapliga studier av gruppen måttligt för tidigt födda 
barn efter moderniseringen av västerländsk nyföddhetsvård. Den här avhandlingen 
avser att belysa de måttligt för tidigt födda barnen ur ett epidemiologiskt perspektiv, 
med aspekter på vårdtider samt sjuklighet i nyföddhetsperioden. 
 
I delarbete I visar resultaten att nästan hälften av alla barn som ligger inne på 
nyföddhetsavdelningarna är födda i graviditetsvecka 30-34. Under en 20-årsperiod har 
dessa barns vårdtider kortats med en dryg vecka utan att sjukligheten minskat. Den 
största förändringen i vårdtid skedde i slutet av 90-talet och början av 2000-talet. Dessa 
fynd tillskrivs främst organisatoriska förändringar i vården, såsom införandet av 
hemsjukvård och individualiserad omvårdnad (NIDCAP) för nyfödda barn. 
 
Med delarbete II, en större studie som innefattar 63% av alla neonatalavdelningar i 
Sverige, kunde vi visa att vårdtiderna för denna grupp barn skiljde sig med upp till två 
veckor mellan olika svenska sjukhus. När vi tagit hänsyn till graviditetstidens längd, 
hade inte barnens sjuklighet i sig någon stor effekt på vårdtidens längd medan 
organisatoriska faktorer såsom sjukhusstorlek, sjukhusnivå, möjlighet till samvård av 
mamma och barn samt tillgång till hemsjukvård verkade vara betydelsefulla. Amning 
minskade tiden på sjukhus jämfört med uppfödning på flaska. 
 
Dessa studier av vårdtider indikerar att man med hjälp av en genomtänkt 
vårdorganisation och införande av hemsjukvård med möjlighet till syrgasbehandling, 
sondmatning, apnélarm och stöd av specialutbildad sjuksköterska, kan begränsa tiden 
på sjukhus för denna grupp barn utan att riskera deras hälsa. Detta ger fördelar för både 
barnets och familjens välmående samtidigt som man får en trygg övergång från 
sjukhustiden till att klara av att själv ta hand om sitt barn hemma. Dessutom frigör man 
resurser och sängplatser från neonatalavdelningen som kan användas till att övervaka 
och behandla de allra mest ömtåliga, extremt för tidigt födda barnen. 
 
Då ett barn föds i graviditetsvecka 30-34, förväntar sig i allmänhet både föräldrar och 
vårdpersonal att nyföddhetsperioden ska förlöpa godartat och komplikationsfritt. I 
landsomfattande svenska studier under tiden 2004-2008 kan vi nu bekräfta data från 
bland annat USA och visa att de måttligt för tidigt födda bär på en väsentlig risk att 
insjukna och behöva behandlingsinsatser i nyföddhetsperioden. De vanligaste 
diagnoserna är, förutom nyföddhetsgulsot och lågt blodsocker, akuta 
andningssjukdomar, som drabbar 28 % av de måttligt underburna barnen. Risken att 
drabbas av en komplikation ökar med sjunkande graviditetslängd för majoriteten av 
diagnoserna. Tillväxthämning under fosterlivet var vanligare bland de mer omogna 
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barnen och detta tillstånd ökade också risken att insjukna i merparten av de studerade 
diagnoserna hos de nyfödda. 
  
I delarbete 4 bestämdes risken att drabbas av ett antal andningssjukdomar hos 4,679 
måttligt för tidigt födda barn jämfört med en referenspopulation av 467,629 svenska 
barn födda i graviditetsvecka 35-41 under samma tidsperiod. De måttligt underburna 
hade en avsevärt ökad risk att drabbas av akuta andningssjukdomar. Risken att drabbas 
av pulmonell adaptationsstörning (TTN) var 23 gånger större och risken att insjukna i 
akut lungsjukdom (RDS) var 180 gånger större för måttligt för tidigt födda jämfört med 
referenspopulationen. Inom gruppen måttligt för tidigt födda barn genomfördes en 
riskanalys av faktorer hos mamma, graviditet, förlossning och barn. Följande faktorer 
ökade risken att insjukna i akuta andningssjukdomar (TTN och/eller RDS) inom 
gruppen måttligt för tidigt födda barn: kejsarsnitt, hög omognadsgrad, låga Apgarpoäng 
vid födelsen och manligt kön. För tidig hinnbristning, behandling med kortikosteroider 
före förlossningen samt tillväxthämning var skyddande mot RDS. Mammans ålder, 
kroniska sjuklighet och rökvanor hade ingen effekt på risken att insjukna i akuta 
andningssjukdomar. 
 
I det dagliga arbetet på landets sjukhus, kan denna nya information om sjuklighet hos 
måttligt för tidigt födda både bidra till ett bättre och mer riskanpassat omhändertagande 
redan vid förlossningen, samt vara ett argument i diskussionerna mellan 
förlossningsläkare och barnläkare vid hotande för tidig förlossning. Resultaten pekar 
tydligt på vinsten av att senarelägga förlossningen i de fall då det är möjligt, även vid 
graviditetslängder som närmar sig fullgångna. Vidare kan nyfödda barn med 
identifierade riskfaktorer hållas under särskild uppsikt med avseende på akuta 
andningssymtom, och få snabbare behandling med bättre resultat. Föräldrar som står 
inför risken att föda i graviditetsvecka 30-34 kan bättre informeras om vad som kan 
vänta deras barn efter förlossningen. 
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